Advanced search
Publication Cover
Drug Metabolism Reviews Volume 37, 2005 - Issue 2
Submit an article Journal homepage
502
Views
60
CrossRef citations to date
0
Altmetric
Research Article

An Interethnic Comparison of Polymorphisms of the Genes Encoding Drug-Metabolizing Enzymes and Drug Transporters: Experience in Singapore

Balram Chowbay Laboratory of Clinical Pharmacology, Division of Clinical Trials and Epidemiological Sciences, National Cancer Centre, Singapore
, Ph.D.,
Dr. Shufeng Zhou Department of Pharmacy, Faculty of Science, National University of Singapore, Singapore
, Ph.D. &
Edmund J. D. Lee Department of Pharmacology, Faculty of Medicine, National University of Singapore, Singapore
, Ph.D.
Pages 327-378 | Published online: 09 Oct 2008

References

  • Agundez, J. A. G., Lozano, L., Ladero, J. M., Sastre, J., Cerdan, F. J., Diaz-Rubio, M., Benitez, J. (2000). N-acetyltransferase 2 (NAT2) genotype and colorectal carcinoma: risk variability according to tumour site?Scand. J. Gastroenterol. 35:1087–1091. [PUBMED], [INFOTRIEVE]
  • Ahmad, H., Wilson, D. E., Fritz, R. R., Singh, S. V., Medh, R. D., Nagle, G. T., Awasthi, Y. C., Kurosky, A. (1990). Primary and secondary analyses of glutathione S-transferase P1 from human placenta.Arch. Biochem. Biophys. 287:398–408. [CROSSREF]
  • Akaba, K., Kimura, T., Sasaki, A., Tanabe, S., Ikegami, T., Hashimoto, M., Umeda, H., Yoshida, H., Umetsu, K., Chiba, H., Yuasa, I., Hayasaka, K. (1998). Neonatal hyperbilirubinaemia and mutation of the bilirubin uridine-diphosphateglucuronosyl-transferase gene: a common missense mutation among Japanese, Koreans and Chinese.Biochem. Mol. Biol. Int. 46:21–26. [PUBMED], [INFOTRIEVE], [CSA]
  • Akaba, K., Kimura, T., Sasaki, A., Tanabe, S., Wakabayashi, T., Hiroi, M., Yasumura, S., Maki, K., Aikawa, S., Hayasaka, K. (1999). Neonatal hyperbilirubinemia and a common mutation of the bilirubin uridine diphosphate-glucuronosyltransferase gene in Japanese.J. Hum. Genet. 44:22–25. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Aktas, D., Guney, I., Alikasifoglu, M., Yuce, K., Tuncbilek, E., Ayhan, A. (2002). CYP1A1 gene polymorphism and risk of epithelial ovarian neoplasm.Gynecol. Oncol. 86:124–128. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Ambudkar, S. V., Dey, S., Hrycyna, C. A., Ramachandra, M., Pastan, I., Gottesman, M. M. (1999). Biochemical, cellular, and pharmacological aspects of the multidrug transporter.Annu. Rev. Pharmacol. Toxicol. 39:361–398. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Ameyaw, M. M., Collie-Duguid, E. S., Powrie, R. H., Ofori-Adjei, D., McLeod, H. L. (1999). Thiopurine methyltransferase alleles in British and Ghanaian populations.Hum. Mol. Genet. 8:367–370. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Anderer, G., Schrappe, M., Brechlin, A. M., Lauten, M., Muti, P., Welte, K., Stanulla, M. (2000). Polymorphisms within glutathione S-transferase genes and initial response to glucocorticoids in childhood acute lymphoblastic leukaemia.Pharmacogenetics 10:715–726. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Ando, Y., Chida, M., Nakayama, K., Saka, H., Kamataki, T. (1998a). The UGT1A1*28 allele is relatively rare in a Japanese population.Pharmacogenetics, 8:357–360. [PUBMED], [INFOTRIEVE], [CSA]
  • Ando, Y., Saka, H., Asai, G., Sugiura, S., Shimokata, K., Kamataki, T. (1998b). UGT1A1 genotypes and glucuronidation of SN-38, the active metabolite of irinotecan.Ann. Oncol. 9:845–847. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Ando, Y., Saka, H., Ando, M., Sawa, T., Muro, K., Ueoka, H., Yokoyama, A., Saitoh, S., Shimokata, K., Hasegawa, Y. (2000). Polymorphisms of UDP-glucuronosyltransferase gene and irinotecan toxicity: a pharmacogenetic analysis.Cancer Res. 60:6921–6926. [PUBMED], [INFOTRIEVE]
  • Ando, Y., Ueoka, H., Sugiyama, T., Ichiki, M., Shimokata, K., Hasegawa, Y. (2002). Polymorphisms of UDP-glucuronosyltransferase and pharmacokinetics of irinotecan.Ther. Drug Monit. 24:111–116. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Anitha, A., Banerjee, M. (2003). Arylamine N-acetyltransferase 2 polymorphism in the ethnic populations of South India.Int. J. Mol. Med. 11:125–131. [PUBMED], [INFOTRIEVE], [CSA]
  • Aono, S., Yamada, Y., Keino, H., Sasaoka, Y., Nakagawa, T., Onishi, S., Mimura, S., Koiwai, O., Sato, H. (1994). A new type of defect in the gene for bilirubin uridine 5′-diphosphate-glucuronosyltransferase in a patient with Crigler-Najjar syndrome type I.Pediatr. Res. 35:629–632. [PUBMED], [INFOTRIEVE], [CSA]
  • Aoyama, T., Yamano, S., Waxman, D. J., Lapenson, D. P., Meyer, U. A., Fischer, V., Tyndale, R., Inaba, T., Kalow, W., Gelboin, H. V., Gonzalez, F. J. (1989). Cytochrome P-450 hPCN3, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver. cDNA and deduced amino acid sequence and distinct specificities of cDNA-expressed hPCN1 and hPCN3 for the metabolism of steroid hormones and cyclosporine.J. Biol. Chem. 264:10388–10395. [PUBMED], [INFOTRIEVE]
  • Aplenc, R., Glatfelter, W., Han, P., Rappaport, E., La, M., Cnaan, A., Blackwood, M. A., Lange, B., Rebbeck, T. (2003). CYP3A genotypes and treatment response in paediatric acute lymphoblastic leukaemia.Br. J. Haematol. 122:240–244. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Ball, S. E., Scatina, J., Kao, J., Ferron, G. M., Fruncillo, R., Mayer, P., Weinryb, I., Guida, M., Hopkins, P. J., Warner, N., Hall, J. (1999). Population distribution and effects on drug metabolism of a genetic variant in the 5′ promoter region of CYP3A4.Clin. Pharmacol. Ther. 66:288–294. [PUBMED], [INFOTRIEVE], [CSA]
  • Balram, C., Sabapathy, K., Fei, G., Khoo, K. S., Lee, E. J. (2002). Genetic polymorphisms of UDP-glucuronosyltransferase in Asians: UGT1A1*28 is a common allele in Indians.Pharmacogenetics, 12:81–83. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Balram, C., Tan, E. H., Zhou, Q. Y., Cheung, Y. B. (2003a). Genetic polymorphisms of UGT1A1 in three Asian populations and pharmacodynamics of irinotecan (CPT-11) in nasopharyngeal carcinoma patients.J. Hong Kong Coll. Radiol. 6:79. [CSA]
  • Balram, C., Zhou, Q., Cheung, Y. B., Lee, E. J. (2003b). CYP3A5*3 and *6 single nucleotide polymorphisms in three distinct Asian populations.Eur. J. Clin. Pharmacol. 59:123–126. [PUBMED], [INFOTRIEVE], [CSA]
  • Ban, N., Takahashi, Y., Takayama, T., Kura, T., Katahira, T., Sakamaki, S., Niitsu, Y. (1996). Transfection of glutathione S-transferase (GST)-antisense complementary DNA increases the sensitivity of a colon cancer cell line to adriamycin, cisplatin, melphalan, and etoposide.Cancer Res. 56:3577–3582., [PUBMED], [INFOTRIEVE]
  • Bell, D. A., Taylor, J. A., Butler, M. A., Stephens, E. A., Wiest, J., Brubaker, L. H., Kadlubar, F. F., Lucier, G. W. (1993). Genotype/phenotype discordance for human arylamine N-acetyltransferase (NAT2) reveals a new slow-acetylator allele common in African–Americans.Carcinogenesis 14:1689–1692. [PUBMED], [INFOTRIEVE], [CSA]
  • Bencharit, S., Morton, C. L., Howard-Williams, E. L., Danks, M. K., Potter, P. M., Redinbo, M. R. (2002). Structural insights into CPT-11 activation by mammalian carboxylesterases.Nat. Struct. Biol. 9:337–342. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Berthou, F., Dreano, Y., Belloc, C., Kangas, L., Beaune, P. (1994). Involvement of cytochrome P450 3A in the major metabolic pathways of toremifene in human liver microsomes.Biochem. Pharmacol. 47:1883–1895. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Bertilsson, G., Heidrich, J., Svensson, K., Osman, M., Jendeberg, L., Sydow-Bäckman, M., Ohlsson, R., Postlind, H., Blomquist, P., Berkenstam, A. (1998). Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction.Proc. Natl. Acad. Sci. U. S. A. 95:12208–12213. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Beutler, E., Gelbert, T., Demina, A. (1998). Racial variability in the UDP-glucuronosyltransferase I (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism?Proc. Natl. Acad. Sci. U. S. A. 95:8170–8174. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Blanco, J. G., Edick, M. J., Hancock, M. L., Winick, N. J., Dervieux, T., Amylon, M. D., Bash, R. O., Behm, F. G., Camitta, B. M., Pui, C. H., Raimondi, S. C., Relling, M. V. (2002). Genetic polymorphisms in CYP3A5, CYP3A4 and NQO1 in children who developed therapy-related myeloid malignancies.Pharmacogenetics 12:605–611. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Blum, M., Demierre, A., Grant, D. M., Heim, M., Meyer, U. A. (1991). Molecular mechanism of slow acetylation of drugs and carcinogens in humans.Proc. Natl. Acad. Sci. U. S. A. 88:5237–5241. [PUBMED], [INFOTRIEVE], [CSA]
  • Board, P. G. (1981). Biochemical genetics of glutathione S-transferase in man.Am. J. Hum. Genet. 33:36–43. [PUBMED], [INFOTRIEVE]
  • Bosland, M. C. (2000). The role of steroid hormones in prostate carcinogenesis.J. Natl. Cancer Inst. Monographs 27:39–66. [PUBMED], [INFOTRIEVE]
  • Bosma, P. J., Goldhoorn, B., Oude Elferink, R. P., Sinaasappel, M., Oostra, B. A., Jansen, P. L. (1993). A mutation in bilirubin uridine 5′-diphosphate-glucuronosyltransferase isoform I causing Crigler-Najjar syndrome type II.Gastroenterology 105:216–220. [PUBMED], [INFOTRIEVE]
  • Bosma, P. J., Chowdhury, J. R., Bakker, C., Gantla, S., de Boer, A., Oostra, B. A., Lindhout, D., Tytgat, G. N., Jansen, P. L., Oude Elferink, R. P. (1995). The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome.N. Engl. J. Med. 333:1171–1175. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Bowen, D. T., Frew, M. E., Rollinson, S., Roddam, P. L., Dring, A., Smith, M. T., Langabeer, S. E., Morgan, G. J. (2003). CYP1A1*2B (Val) allele is overrepresented in a subgroup of acute myeloid leukemia patients with poor-risk karyotype associated with NRAS mutation, but not associated with FLT3 internal tandem duplication.Blood, 101:2770–2774. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Boysen, G., Kenney, P. M., Upadhyaya, P., Wang, M., Hecht, S. S. (2003). Effects of benzyl isothiocyanate and 2-phenethyl isothiocyanate on benzo[a]pyrene and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone metabolism in F-344 rats.Carcinogenesis 24:517–525. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Brockmoller, J., Kerb, R., Drakoulis, N., Nitz, M., Roors, I. (1993). Genotype and phenotype of glutathione S-transferase class isozymes and in lung cancer patients and controls.Cancer Res. 53:1004–1011. [PUBMED], [INFOTRIEVE]
  • Brockmoller, J., Cascorbi, I., Kerb, R., Roots, I. (1996). Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase. 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk.Cancer Res. 56:3915–3925. [PUBMED], [INFOTRIEVE]
  • Brooks, B. A., McBride, O. W., Dolphin, C. T., Farrall, M., Scambler, P. J., Gonzalez, F. J., Idle, J. R. (1988). The gene CYP3 encoding P-450pcn1 (nifedipine oxidase) is tightly linked to thegene COL1A2 encoding collagen type 1 alpha on 7q21-q22.1.Am. J. Hum. Genet. 43:280–284. [PUBMED], [INFOTRIEVE], [CSA]
  • Butcher, N. J., Boukouvala, S., Sim, E., Minchin, R. F. (2002). Pharmacogenetics of the arylamine N-acetyltransferases.Pharmacogenomics J. 2:30–42. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Callen, D. F., Baker, E., Simmers, R. N., Seshadri, R., Roninson, I. B. (1987). Localization of the human multiple drug resistance gene, MDR1, to 7q21.1.Hum. Genet. 77:142–144. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Canal, P., Gay, C., Dezeuze, A., Douillard, J. Y., Bugat, R., Brunet, R., Adenis, A., Herait, P., Lokiec, F., Mathieu-Boue, A. (1996). Pharmacokinetics and pharmacodynamics of irinotecan during a phase II clinical trial in colorectal cancer. Pharmacology and molecular mechanisms group of the european organization for research and treatment of cancer.J. Clin. Oncol. 14:2688–2695. [PUBMED], [INFOTRIEVE]
  • Cascorbi, I., Drakoulis, N., Brockmoller, J., Maurer, A., Sperling, K., Roots, I. (1995). Arylamine N-acetyltransferase (NAT2) mutations and their allelic linkage in unrelated Caucasian individuals: correlation with phenotypic activity.Am. J. Hum. Genet. 57:581–592. [PUBMED], [INFOTRIEVE], [CSA]
  • Cascorbi, I., Brockmoller, J., Roots, I. (1996). A C4887A polymorphism in exon 7 of human CYP 1A1: population frequency, mutation linkages, and impact on lung cancer susceptibility.Cancer Res. 56:4965–4969. [PUBMED], [INFOTRIEVE]
  • Cascorbi, I., Gerloff, T., Johne, A., Meisel, C., Hoffmeyer, S., Schwab, M., Schaeffeler, E., Eichelbaum, M., Brinkmann, U., Roots, I. (2001a). Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects.Clin. Pharmacol. Ther. 69:169–174. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Cascorbi, I., Roots, I., Brockmoller, J. (2001b). Association of NAT1 and NAT2 polymorphisms to urinary bladder cancer: significantly reduced risk in subjects with NAT1*10.Cancer Res. 61:5051–5056. [PUBMED], [INFOTRIEVE]
  • Cavaco, I., Reis, R., Gil, J. P., Ribeiro, V. (2003). CYP3A4*1B and NAT2*14 alleles in a native African population.Clin. Chem. Lab. Med. 41:606–609. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Chang, B. L., Zheng, S. L., Isaacs, S. D., Turner, A., Hawkins, G. A., Wiley, K. E., Bleecker, E. R., Walsh, P. C., Meyers, D. A., Isaacs, W. B., Xu, J. (2003). Polymorphisms in the CYP1A1 gene are associated with prostate cancer risk.Int. J. Cancer 106:375–378. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Chen, C.-J., Chin, J. E., Ueda, K., Clark, D. P., Pastan, I., Gottesman, M. M., Roninson, I. B. (1996). Internal duplication and homology with bacterial transport proteins in mdr1 (P-glycoprotein) gene from multidrug-resistant human cells.Cell 47:381–389. [CROSSREF]
  • Chen, C.-L., Liu, Q., Pui, C. H., Rivera, G. K., Sandlund, J. T., Ribeiro, R., Evans, W. E., Relling, M. V. (1997). Higher frequency of glutathione S-transferase deletions in black children with acute lymphoblastic leukemia.Blood 89:1701–1707. [PUBMED], [INFOTRIEVE], [CSA]
  • Chen, S., Xue, K., Xu, L., Ma, G., Wu, J. (2001). Polymorphisms of the CYP1A1 and GSTM1 genes in relation to individual susceptibility to lung carcinoma in Chinese population.Mutat. Res. 458:41–47. [PUBMED], [INFOTRIEVE]
  • Childs, S., Yeh, R. L., Hui, D., Ling, V. (1998). Taxol resistance mediated by transfection of the liver-specific sister gene of P-glycoprotein.Cancer Res. 58:4160–4167. [PUBMED], [INFOTRIEVE]
  • Ching, M., Bichara, N., Blake, C. L., Ghabrial, H., Tukey, R. H., Smallwood, R. A. (1996). Propranolol 4-and 5-hydroxylation and N-desisopropylation by cloned human cytochrome P4501A1 and 1A2.Drug Metab. Dispos. 24:692–695. [PUBMED], [INFOTRIEVE], [CSA]
  • Chou, F. C., Tzeng, S. J., Huang, J. D. (2001). Genetic polymorphism of cytochrome P450 3A5 in Chinese.Drug Metab. Dispos. 29:1205–1209. [PUBMED], [INFOTRIEVE], [CSA]
  • Chowbay, B., Cumaraswamy, S., Cheung, Y. B., Zhou, Q., Lee, E. J. (2003). Genetic polymorphisms in MDR1 and CYP3A4 genes in Asians and the influence of MDR1 haplotypes on cyclosporin disposition in heart transplant recipients.Pharmacogenetics, 13:89–95. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Ciotti, M., Yeatman, M. T., Sokol, R. J., Owens, I. S. (1995). Altered coding for a strictly conserved di-glycine in the major bilirubin UDP-glucuronosyltransferase of a Crigler–Najjar type I patient.J. Biol. Chem. 270:3284–3291., [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Coles, B. F., Morel, F., Rauch, C., Huber, W. W., Yang, M., Teitel, C. H., Green, B., Lang, N. P., Kadlubar, F. F. (2001). Effect of polymorphisms in the human glutathione S-transferase A1 promoter on hepatic GSTA1 and GSTA2 expression.Pharmacogenetics, 11:663–669. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Collie-Duguid, E. S., Pritchard, S. C., Powrie, R. H., Sludden, J., Collier, D. A., Li, T., McLeod, H. L. (1999). The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations.Pharmacogenetics 9:37–42. [PUBMED], [INFOTRIEVE], [CSA]
  • Colombel, J. F., Ferrari, N., Debuysere, H., Marteau, P., Gendre, J. P., Bonaz, B., Soule, J. C., Modigliani, R., Touze, Y., Catala, P., Libersa, C., Broly, F. (2000). Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy.Gastroenterology, 118:1025–1030. [PUBMED], [INFOTRIEVE], [CSA]
  • Cosma, G., Crofts, F., Currie, D., Wirgin, I., Toniolo, P., Garte, S. J. (1993a). Racial differences in restriction fragment length polymorphisms and messenger RNA inducilibility of the human CYP1A1 gene.Cancer Epidemiol. Biomark. Prev. 2:53–57.
  • Cosma, G., Crofts, F., Taioli, E., Toniolo, P., Garte, S. (1993b). Relationship between genotype and function of the human CYP1A1 gene.J. Toxicol. Envion. Health, 40:309–316.
  • Coulthard, S. A., Rabello, C., Robson, J., Howell, C., Minto, L., Middleton, P. G., Gandhi, M. K., Jackson, G., McLelland, J., O'Brien, H., Smith, S., Reid, M. M., Pearson, A. D., Hall, A. G. (2000). A comparison of molecular and enzyme-based assays for the detection of thiopurine methyltransferase mutations.Br. J. Haematol. 110:599–604. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • da Fonte de Amorim, L., Rossini, A., Mendonca, G., Lotsch, P., de Almeida Simao, T., de Moura Gallo, C., Pinto, L. (2002). CYP1A1, GSTM1, and GSTT1 polymorphisms and breast cancer risk in Brazilian women.Cancer Lett. 181:179–186. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Dai, D., Tang, J., Rose, R., Hodgson, E., Bienstock, R. J., Mohrenweiser, H. W., Goldstein, J. A. (2001). Identification of variants of CYP3A4 and characterization of their abilities to metabolize testosterone and chlorpyrifos.J. Pharmacol. Exp. Ther. 299:825–831. [PUBMED], [INFOTRIEVE], [CSA]
  • Dandara, C., Masimirembwa, C. M., Magimba, A. K. S., Sayi, J., Sommers de, K., Snyman, J. R., Hasler, J. A. (2003). Arylamine N-acetyltransferase (NAT2) genotypes in Africans: the identification of a new allele with nucleotide changes 481C > T and 590G > A.Pharmacogenetics, 13:55–58. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • DeJong, J. L., Chang, C., Whang-Peng, J., Knutsen, T., Tu, C. P. (1988). The human liver glutathione transferase gene superfamily: expression and chromosome mapping of Hb subunit cDNA.Nucleic Acids Res. 16:8543–8554.
  • Delomenie, C., Sica, L., Grant, D. M., Krishnamoorthy, R., Dupret, J. M. (1996). Genotyping of the polymorphic N-acetyltransferase (NAT2*) gene locus in two native African populations.Pharmacogenetics, 6:177–185. [PUBMED], [INFOTRIEVE], [CSA]
  • Deninson, M. S., Fisher, J. M., Whitlock, J. P. Jr. (1988). Inducible, receptor-dependent protein-DNA interactions at a dioxin-responsive transcriptional enhancer.Proc. Natl. Acad. Sci. U. S. A. 85:2528–2532. [CSA]
  • Dervieux, T., Medard, Y., Baudouin, V., Maisin, A., Zhang, D., Broly, F., Loirat, C., Jacqz-Aigrain, E. (1999). Thiopurine methyltransferase activity and its relationship to the occurrence of rejection episodes in paediatric renal transplant recipients treated with azathioprine.Br. J. Clin. Pharmacol. 48:793–800. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Dialyna, I. A., Arvanitis, D. A., Spandidos, D. A. (2001). Genetic polymorphisms and transcriptional pattern analysis of CYP1A1, AhR, GSTM1, GSTP1 and GSTT1 genes in breast cancer.Int. J. Mol. Med. 8:79–87. [PUBMED], [INFOTRIEVE], [CSA]
  • Domanski, T. L., Finta, C., Halpert, J. R., Zaphiropoulos, P. G. (2001). cDNA cloning and initial characterization of CYP3A43, a novel human cytochrome P450.Mol. Pharmacol. 59:386–392. [PUBMED], [INFOTRIEVE], [CSA]
  • Drakoulis, N., Cascorbi, I., Brockmoller, J., Gross, C. R., Roots, I. (1994). Polymorphisms in the human CYP1A1 gene as susceptibility factors for lung cancer: exon-7 mutation (4889 A to G), and a T to C mutation in the 3′-flanking region.Clin. Investig. 72:240–248., [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Drescher, S., Schaeffeler, E., Hitzl, M., Hofmann, U., Schwab, M., Brinkmann, U., Eichelbaum, M., Fromm, M. F. (2002). MDR1 gene polymorphisms and disposition of the P-glycoprotein substrate fexofenadine.Br. J. Clin. Pharmacol. 53:526–534. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Dubinsky, M. C., Hassard, P. V., Seidman, E. G., Kam, L. Y., Abreu, M. T., Targan, S. R., Vasiliauskas, E. A. (2001). An open-label pilot study using thioguanine as a therapeutic alternative in Crohn's disease patients resistant to 6-mercaptopurine therapy.Inflamm Bowel Dis. 7:181–189. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Dubinsky, M. C., Yang, H., Hassard, P. V., Seidman, E. G., Kam, L. Y., Abreu, M. T., Targan, S. R., Vasiliauskas, E. A. (2002). 6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease.Gastroenterology 122:904–915. [PUBMED], [INFOTRIEVE], [CSA]
  • Duell, E. J., Holly, E. A., Bracci, P. M., Liu, M., Wiencke, J. K., Kelsey, K. T. A population-based, case-control study of polymorphisms in carcinogen-metabolizing genes, smoking, and pancreatic adenocarcinoma risk.J. Natl. Cancer Inst. (2002)94:297–306. [PUBMED], [INFOTRIEVE]
  • Ebisawa, T., Deguchi, T. (1991). Structure and restriction fragment length polymorphism of genes for human liver arylamine N-acetyltransferase.Biochem. Biophys. Res. Commun. 177:1252–1257. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Evans, D. A. (1989). N-acetyltransferase.Pharmacol. Ther. 42:157–234. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Evans, W. E., McLeod, H. L. (2003). Pharmacogenomics-drug disposition, drug targets, and side effects.N. Engl. J. Med. 348:538–549. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Evans, W. E., Relling, M. V. (1999). Pharmacogenomics: translating functional genomics into rational therapeutics.Science 286:487–491. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Evans, W. E., Horner, M., Chu, Y. Q., Kalwinsky, D., Roberts, W. M. (1991). Altered mercaptopurine metabolism, toxic effects and dosage requirement in a thiopurine methyltransferase-deficient child with acute lymphocytic leukemia.J. Pediatr. 119:985–989. [PUBMED], [INFOTRIEVE]
  • Evans, D. A., McLeod, H. L., Pritchard, S., Tariq, M., Mobarek, A. (2001a). Interethnic variability in human drug responses.Drug Metab. Dispos. 29:606–610. [PUBMED], [INFOTRIEVE], [CSA]
  • Evans, W. E., Hon, Y. Y., Bomgaars, L., Coutre, S., Holdsworth, M., Janco, R., Kalwinsky, D., Keller, F., Khatib, Z., Margolin, J., Murray, J., Quinn, J., Ravindranath, Y., Ritchey, K., Roberts, W., Rogers, Z. R., Schiff, D., Steuber, C., Tucci, F., Kornegay, N., Krynetski, E. Y., Relling, M. V. (2001b). Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine.J. Clin. Oncol. 19:2293–2301. [PUBMED], [INFOTRIEVE]
  • Felix, C. A., Walker, A. H., Lange, B. J., Williams, T. M., Winick, N. J., Cheung, N. K., Lovett, B. D., Nowell, P. C., Blair, I. A., Rebbeck, T. R. (1998). Association of CYP3A4 genotype with treatment-related leukemia.Proc. Natl. Acad. Sci. U. S. A. 95:13176–13181. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Fellay, J., Marzolini, C., Meaden, E. R., Back, D. J., Buclin, T., Chave, J. P., Decosterd, L. A., Furrer, H., Opravil, M., Pantaleo, G., Retelska, D., Ruiz, L., Schinkel, A. H., Vernazza, P., Eap, C. B., Telenti, A., Telenti, A., Swiss HIV Cohort Study. (2002). Response to antiretroviral treatment in HIV-1 infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study.Lancet 359:30–36. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Fessing, M. Y., Krynetski, E. Y., Zambetti, G. P., Evans, W. E. (1998). Functional characterization of the human thiopurine S-methyltransferase (TPMT) gene promoter.Eur. J. Biochem. 256:510–517. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Finta, C., Zaphiropoulos, P. G. (2000). The human cytochrome P450 3A locus. Gene evolution by capture of downstream exons.Gene 260:13–23. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Fischer, V., Johanson, L., Heitz, F., Tullman, R., Graham, E., Baldeck, J. B., Robinson, W. T. (1999). The 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor fluvastatin: effect on human cytochrome P-450 and implications for metabolic drug interactions.Drug Metab. Dispos. 27:410–416. [PUBMED], [INFOTRIEVE], [CSA]
  • Fisher, M. B., VandenBranden, M., Findlay, K., Burchell, B., Thummel, K. E., Hall, S. D., Wrighton, S. A. (2000). Tissue distribution and interindividual variation in human UDP-glucuronosyltransferase activity: relationship between UGT1A1 promoter genotype and variability in a liver bank.Pharmacogenetics 10:727–739. [CSA], [CROSSREF]
  • Fisher, M. B., Paine, M. F., Strelevitz, T. J., Wrighton, S. A. (2001). The role of hepatic and extrahepatic UDP-glucuronosyltransferases in human drug metabolism.Drug Metab. Rev. 33:273–297. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Fromm, M. F., Kim, R. B., Stein, C. M., Wilkinson, G. R., Roden, D. M. (1999). Inhibition of P-glycoprotein-mediated drug transport: a unifying mechanism to explain the interaction between digoxin and quinidine.Circulation 99:552–557. [PUBMED], [INFOTRIEVE], [CSA]
  • Fryer, A. A., Zhao, L., Alldersea, J., Boggild, M. D., Perrett, C. W., Clayton, R. N., Jones, P. W., Strange, R. C. (1993). The glutathione S-transferase: polymerase chain reaction studies on the frequency of the GSTM1*0 genotype in patients with pituitary adenomas.Carcinogenesis 14:563–566. [PUBMED], [INFOTRIEVE]
  • Fukuen, S., Fukuda, T., Maune, H., Ikenaga, Y., Yamamoto, I., Inaba, T., Azuma, J. (2002). Novel detection assay by PCR-RFLP and frequency of the CYP3A5 SNPs, CYP3A5*3 and *6, in a Japanese population.Pharmacogenetics 12:331–334. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Gagne, J. F., Montminy, V., Belanger, P., Journault, K., Gaucher, G., Guillemette, C. (2002). Common human UGT1A polymorphisms and the altered metabolism of irinotecan active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38).Mol. Pharmacol. 62:608–617. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Garcia-Martin, E., Martinez, C., Pizarro, R. M., Garcia-Gamito, F. J., Gullsten, H., Raunio, H., Agundez, J. A. G. (2002). CYP3A4 variant alleles in white individuals with low CYP3A4 enzyme activity.Clin. Pharmacol. Ther. 71:196–204. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Garte, S. (1998). The role of ethnicity in cancer susceptibility gene polymorphisms: the example of CYP1A1.Carcinogenesis 19:1329–1332. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Gellner, K., Eiselt, R., Hustert, E., Arnold, H., Koch, I., Haberl, M., Deglmann, C. J., Burk, O., Buntefuss, D., Escher, S., Bishop, C., Koebe, H. G., Brinkmann, U., Klenk, H. P., Kleine, K., Meyer, U. A., Wojnowski, L. (2001). Genomic organization of the human CYP3A locus: identification of a new, inducible CYP3A gene.Pharmacogenetics 11:111–121. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Gibson, G. G., Plant, N. J., Swales, K. E., Ayrton, A., El-Sankary, W. (2002). Receptor-dependent transcriptional activation of cytochrome P4503A genes: induction mechanisms, species differences and interindividual variation in man.Xenobiotica, 32:165–206. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Givens, R. C., Lin, Y. S., Dowling, A. L., Thummel, K. E., Lamba, J. K., Schuetz, E. G., Stewart, P. W., Watkins, P. B. (2003). CYP3A5 genotype predicts renal CYP3A activity and blood pressure in healthy adults.J Appl Physiol 95:1297–1300. [PUBMED], [INFOTRIEVE]
  • Glatt, H., Engelke, C. E., Pabel, U., Teubner, W., Jones, A. L., Coughtrie, M. W., Andrae, U., Falany, C. N., Meinl, W. (2000). Sulfotransferases: genetics and role in toxicology.Toxicol. Lett. 112–113:341–348. [CROSSREF]
  • Golka, K., Prior, V., Blaszkewicz, M., Bolt, H. M. (2002). The enhanced bladder cancer susceptibility of NAT2 slow acetylators towards aromatic amines: a review considering ethnic differences.Toxicol. Lett. 128:229–241. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Gonzalez, F. J., Schmid, B. J., Umeno, M., McBridge, O. W., Hardwick, J. P., Meyer, U. A., Gelboin, H. V., Idle, J. R. (1988). Human P450PCN1: sequence, chromosome localization, and direct evidence through cDNA expression that P450PCN1 is nifedipine oxidase.DNA 7:79–86. [PUBMED], [INFOTRIEVE]
  • Goodwin, B., Hodgson, E., Liddle, C. (1999). The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module.Mol. Pharmacol. 56:1329–1339. [PUBMED], [INFOTRIEVE], [CSA]
  • Goodwin, B., Redinbo, M. R., Kliewer, S. A. (2002). Regulation of CYP3A gene transcription by the pregnane X receptor.Annu. Rev. Pharmacol. Toxicol. 42:1–23. [PUBMED], [INFOTRIEVE], [CSA]
  • Goto, M., Masuda, S., Saito, H., Uemoto, S., Kiuchi, T., Tanaka, K., Inui, K. (2002). C3435T polymorphism in the MDR1 gene affects the enterocyte expression level of CYP3A4 rather than Pgp in recipients of living-donor liver transplantation.Pharmacogenetics 12:451–457., [PUBMED], [INFOTRIEVE], [CSA]
  • Gottesman, M. M., Pastan, I. (1993). Biochemistry of multidrug resistance mediated by the multidrug transporter.Annu. Rev. Biochem. 62:385–427. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Graf, T., Broly, F., Hoffman, F., Probst, M., Meyer, U. A., Howald, H. (1992). Prediction of phenotype for acetylation and for debrisoquine hydroxylation by DNA-test in healthy human volunteers.Eur. J. Clin. Pharmacol. 43:399–403. [PUBMED], [INFOTRIEVE]
  • Grant, D. M., Blum, M., Beer, M., Meyer, U. (1991). Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparision of liver isozymes and expressed products of twocloned genes.Mol. Pharmacol. 39:184–191. [PUBMED], [INFOTRIEVE]
  • Grant, D. M., Hughes, N. C., Janezic, S. A., Goodfellow, G. H., Chen, H. J., Gaedigk, A., Yu, V. L., Grewal, R. (1997). Human acetyltransferase polymorphisms.Mutat Res 376:61–70. [PUBMED], [INFOTRIEVE]
  • Guengerich, F. P., Shimada, T. (1998). Activation of procarcinogens by human cytochrome P450 enzymes.Mutat. Res. 400:201–213. [PUBMED], [INFOTRIEVE]
  • Guo, Z., Gillam, E. M., Ohmori, S., Tukey, R. H., Guengerich, F. P. (1994). Expression of modified human cytochrome P450 1A1 in Escherichia coli: effects of 5′ substitution, stabilization, purification, spectral characterization, and catalytic properties.Arch. Biochem. Biophys. 312:436–446. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Gupta, E., Lestingi, T. M., Mick, R., Ramirez, J., Vokes, E. E., Ratain, M. J. (1994). Metabolic fate of irinotecan in humans: correlation of glucuronidation with diarrhea.Cancer Res. 54:3723–3725. [PUBMED], [INFOTRIEVE]
  • Gupta, E., Mick, R., Ramirez, J., Wang, X., Lestingi, T. M., Vokes, E. E., Ratain, M. J. (1997). Pharmacokinetic and pharmacodynamic evaluation of the topoisomerase inhibitor irinotecan in cancer patients.J. Clin. Oncol. 15:1502–1510. [PUBMED], [INFOTRIEVE]
  • Hafkemeyer, P., Dey, S., Ambudkar, S. V., Hrycyna, C. A., Pastan, I., Gottesman, M. M. (1998). Contribution to substrate specificity and transport of nonconserved residues in transmembrane domain 12 of human P-glycoprotein.Biochemistry 37:16400–16409. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Hall, D., Ybazeta, G., Destro-Bisol, G., Petzl-Erler, M. L., Di Rienzo, A. (1999). Variability at the uridine diphosphate glucuronosyltransferase 1A1 promoter in human populations and primates.Pharmacogenetics 9:591–599. [PUBMED], [INFOTRIEVE], [CSA]
  • Hamasaki, T., Inatomi, H., Katoh, T., Aono, H., Ikuyama, T., Muratani, T., Matsumoto, T. (2003). N-acetyltransferase-2 gene polymorphism as a possible biomarker for prostate cancer in Japanese men.Int. J. Urol. 10:167–173. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Hamdy, S. I., Hiratsuka, M., Narahara, K., Endo, N., El-Enany, M., Moursi, N., Ahmed, M. S., Mizugaki, M. (2003). Genotype and allele frequencies of TPMT, NAT2, GST, SULT1A1 and MDR-1 in the Egyptian population.Br. J. Clin. Pharmacol. 55:560–569. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Hamzeiy, H., Vahdati-Mashhadian, N., Edwards, H. J., Goldfarb, P. S. (2002). Mutation analysis of the human CYP3A4 gene 5′ regulatory region: population screening using non-radioactive SSCP.Mutat. Res. 500:103–110. [PUBMED], [INFOTRIEVE]
  • Harada, S., Misawa, S., Nakamura, T., Tanaka, N., Ueno, E., Nozoe, M. (1992). Detection of GST1 gene deletion by the polymerase chain reaction and its possible correlation with stomach cancer in Japanese.Hum. Genet. 90:62–64. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Harada, S., Nakamura, T., Misawa, S. (1994). Polymorphism of pentanucleotide repeats in the 5′ flanking region of the glutathione S-transferase (GST) pi gene.Hum. Genet. 93:223–224. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Harper, P. A., Wong, J. Y., Lam, M. S., Okey, A. B. (2002). Polymorphisms in the human AH receptor.Chem. Biol. Int. 141:161–187. [CSA], [CROSSREF]
  • Hashiguchi, M., Ebihara, A. (1992). Acetylation polymorphism in a Japanese population.Clin. Pharmacol. Ther. 52:274–276. [PUBMED], [INFOTRIEVE], [CSA]
  • Hashimoto, H., Toide, K., Kitamura, R., Fujita, M., Tagawa, S., Itoh, S., Kamataki, T. (1993). Gene structure of CYP3A4, an adult specific form of cytochrome P450 in human livers, and its transcriptional control.Eur. J. Biochem. 218:585–595. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Haugen, A., Willey, J., Borresen, A. L., Tefre, T. (1990). Pst I polymorphism at the human P1450 gene on chromosome 15.Nucleic Acids Res. 18:3114.
  • Hayashi, S., Watanabe, J., Nakachi, K., Kawajiri, K. (1991). Genetic linkage of lung cancer-associated MspI polymorphism with amino acid replacement in the heme binding region of the human cytochrome P450IA1 gene.J. Biochem. 110:407–411. [PUBMED], [INFOTRIEVE]
  • Hayashi, S., Watanabe, J., Kawajiri, K. (1992). High susceptibility to lung cancer analysed in terms of combined genotypes of P450IA1 and Mu-class glutathione S-transferase genes.Jpn. J. Cancer Res. 83:866–870. [PUBMED], [INFOTRIEVE]
  • Hayes, J. D., Pulford, D. J. (1995). The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance.Crit Rev Biochem Mol Biol. 30:445–600. [PUBMED], [INFOTRIEVE], [CSA]
  • Hayes, J. D., Strange, R. C. (1995). Potential contribution of the glutathione S-transferase supergene family to resistance to oxidative stress.Free Radic. Res. 22:193–207. [PUBMED], [INFOTRIEVE], [CSA]
  • Hecht, S. S., Kenney, P. M., Wang, M., Upadhyaya, P. (2002). Benzyl isothiocyanate: an effective inhibitor of polycyclic aromatic hydrocarbon tumorigenesis in A/J mouse lung.Cancer Lett. 187:87–94. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Hein, D. W., Doll, M. A., Fretland, A. J., Leff, M. A., Webb, S. J., Xiao, G. H., Devanaboyina, U. S., Nangju, N. A., Feng, Y. (2000). Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms.Cancer Epidemiol. Biomark. Prev. 9:29–42. [CSA]
  • Henderson, B. E., Feigelson, H. S. (2000). Hormonal carcinogenesis.Carcinogenesis, 21:427–433. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Hickman, D., Risch, A., Buckle, V., Spurr, N. K., Jeremiah, S. J., McCarthy, A., Sim, E. (1994). Chromosomal localisation of human genes for arylamine N-acetyltransferase.Biochem. J. 297:441–445. [PUBMED], [INFOTRIEVE]
  • Hildebrand, C. E., Gonzalez, F. J., McBride, O. W., Nebert, D. W. (1985). Assignment of the human. 2,4,7,8-tetrachlorodibenzo-p-dioxin-inducible cytochrome P1-450 gene to chromosome 15.Nucleic Acids Res. 13:2009–2016. [PUBMED], [INFOTRIEVE]
  • Hiratsuka, M., Inoue, T., Omori, F., Agatsuma, Y., Mizugaki, M. (2000). Genetic analysis of thiopurine methyltransferase polymorphism in a Japanese population.Mutat. Res. 448:91–95. [PUBMED], [INFOTRIEVE]
  • Hiratsuka, M., Takekuma, Y., Endo, N., Narahara, K., Hamdy, S. I., Kishikawa, Y., Matsuura, M., Agatsuma, Y., Inoue, T., Mizugaki, M. (2002). Allele and genotype frequencies of CYP2B6 and CYP3A5 in the Japanese population.Eur. J. Clin. Pharmacol. 58:417–421. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Hirvonen, A., Husgafvel-Pursiainen, K., Karjalainen, A., Anttila, S., Vainio, H. (1992). Point-mutational MspI and Ile-Val polymorphisms closely linked in the CYP1A1 gene: lack of association with susceptibility to lung cancer in a Finnish study population.Cancer Epidemiol. Biomark. Prev. 1:485–489.
  • Hoffmeyer, S., Burk, O., von Richter, O., Arnold, H. P., Brockmoller, J., Johne, A., Cascorbi, I., Gerloff, T., Roots, I., Eichelbaum, M., Brinkmann, U. (2000). Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo.Proc. Natl. Acad. Sci. 97:3473–3478. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Hollenberg, P. F. (2002). Characteristics and common properties of inhibitors, inducers, and activators of CYP enzymes.Drug Metab. Rev. 34:17–35. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Hon, Y. Y., Fessing, M. Y., Pui, C. H., Relling, M. V., Krynetski, E. Y., Evans, W. E. (1999). Polymorphism of the thiopurine S-methyltransferase gene in African–Americans.Hum. Mol. Genet. 8:371–376. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Honchel, R., Aksoy, I. A., Szumlanski, C., Wood, T. C., Otterness, D. M., Wieben, E. D., Weinshilboum, R. M. (1993). Human thiopurine methyltransferase: molecular cloning and expression of T84 colon carcinoma cell cDNA.Mol. Pharmacol. 43:878–887. [PUBMED], [INFOTRIEVE]
  • Houlston, R. S. (1999). Glutathione S-transferase M1 status and lung cancer risk: a meta-analysis.Cancer Epidemiol. Biomark. Prev. 8:675–682. [CSA]
  • Hsieh, F. I., Pu, Y. S., Chern, H. D., Hsu, L. I., Chiou, H. Y., Chen, C. J. (1999). Geneticpolymorphisms of N-acetyltransferase 1 and 2 and risk of cigarette smoking-related bladder cancer.Br. J. Cancer. 81:537–541. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Hsieh, K. P., Lin, Y. Y., Cheng, C. L., Lai, M. L., Lin, M. S., Siest, J. P., Huang, J. D. (2001). Novel mutations of CYP3A4 in Chinese.Drug Metab. Dispos. 29:268–273. [PUBMED], [INFOTRIEVE], [CSA]
  • Huang, C. S., Chern, H. D., Chang, K. J., Cheng, C. W., Hsu, S. M., Shen, C. Y. (1999). Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility.Cancer Res. 59:4870–4875. [PUBMED], [INFOTRIEVE]
  • Huang, C. S., Luo, G. A., Huang, M. J., Yu, S. C., Yang, S. S. (2000a). Variations in the bilirubin uridine-diphosphoglucuronosyl transferase 1A1 gene in healthy Taiwanese.Pharmacogenetics 10:539–544. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Huang, M., Jiang, W. Q., Lou, Y. L., Cheng, M. X. (2000b). Comparison of thiopurine methyltransferase activity between Chinese and Caucasian populations.Chin. J. Cancer. 19:858–861.
  • Huang, Y. S., Chern, H. D., Su, W. J., Wu, J. C., Lai, S. L., Yang, S. Y., Chang, F. Y., Lee, S. D. (2002). Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis.Hepatology 35:883–889. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Hughes, H. B., Biehl, J. P., Jones, A. P., Schmidt, L. H. (1954). Metabolism of isoniazid in man as related to the occurrence of peripheral neuritis.Am. Rev. Respir. Dis. 70:266–273.
  • Humerickhouse, R., Lohrbach, K., Li, L., Bosron, W. F., Dolan, M. E. (2000). Characterization of CPT-11 hydrolysis by human liver carboxylesterase isoforms hCE-1 and hCE-2.Cancer Res. 60:1189–1192. [PUBMED], [INFOTRIEVE]
  • Hung, R. J., Boffetta, P., Brockmoller, J., Butkiewicz, D., Cascorbi, I., Clapper, M. L., Garte, S., Haugen, A., Hirvonen, A., Anttila, S., Kalina, I., Le Marchand, L., London, S. J., Rannug, A., Romkes, M., Salagovic, J., Schoket, B., Gaspari, L., Taioli, E. (2003). CYP1A1 and GSTM1 genetic polymorphisms and lung cancer risk in Caucasian non-smokers: a pooled analysis.Carcinogenesis 24:875–882. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Hustert, E., Haberl, M., Burk, O., Wolbold, R., He, Y. Q., Klein, K., Nuessler, A. C., Neuhaus, P., Klattig, J., Eiselt, R., Koch, I., Zibat, A., Brockmoller, J., Halpert, J. R., Zanger, U. M., Wojnowski, L. (2001). The genetic determinants of the CYP3A5 polymorphism.Pharmacogenetics 11:773–779. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Hyde, S. C., Emsley, P., Hartshorn, M. J., Mimmack, M. M., Gileadi, U., Pearce, S. R., Gallagher, M. P., Gill, D. R., Hubbard, R. E., Higgins, C. F. (1990). Structural model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance and bacterial transport.Nature 346:362–365. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Ilett, K. F., David, B. M., Detchon, P., Castleden, W. M., Kwa, R. (1987). Acetylation phenotype in colorectal carcinoma.Cancer Res. 47:1466–1469. [PUBMED], [INFOTRIEVE]
  • Inoue, K., Inazawa, J., Nakagawa, H., Shimada, T., Yamazaki, H., Guengerich, F. P., Abe, T. (1992). Assignment of the human cytochrome P-450 nifedipine oxidase gene (CYP3A4) to chromosome 7 at band q22.1 by fluorescence in situ hybridization.Jpn. J. Hum. Genet. 37:133–138. [PUBMED], [INFOTRIEVE], [CSA]
  • Inoue, H., Kiyohara, C., Marugame, T., Shinomiya, S., Tsuji, E., Handa, K., Hayabuchi, H., Onuma, K., Hamada, H., Koga, H., Kono, S. (2000). Cigarette smoking, CYP1A1 MspI and GSTM1 genotypes, and colorectal adenomas.Cancer Res. 60:3749–3752. [PUBMED], [INFOTRIEVE]
  • Inskip, A., Elexperu-Camiruaga, J., Buxton, N., Dias, P. S., MacIntosh, J., Campbell, D., Jones, P. W., Yengi, L., Talbot, J. A., Strange, R. C., Fryer, A. A. (1995). Identification of polymorphism at the glutathione S-transferase, GSTM3 locus: evidence for linkage with GSTM1*A.Biochem. J. 312:713–716. [PUBMED], [INFOTRIEVE]
  • Ishibe, N., Wiencke, J. K., Zuo, Z. F., McMillan, A., Spitz, M., Kelsey, K. T. (1997). Susceptibility to lung cancer in light smokers associated with CYP1A1 polymorphisms in Mexican-and African–Americans.Cancer Epidemiol. Biomark. Prev. 6:1075–1080., [CSA]
  • Ishibe, N., Stampfer, M., Hunter, D. J., Hennekens, C., Kelsey, K. T. (2000). A prospective study of cytochrome P450 1A1 polymorphisms and colorectal cancer risk in men.Cancer Epidemiol. Biomark. Prev. 9:855–856. [CSA]
  • Ito, S., Ieiri, I., Tanabe, M., Suzuki, A., Higuchi, S., Otsubo, K. (2001). Polymorphism of the ABC transporter genes, MDR1, MRP1 and MRP2/cMOAT, in healthy Japanese subjects.Pharmacogenetics 11:175–184. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Iyer, L., King, C. D., Whitington, P. F., Green, M. D., Roy, S. K., Tephly, T. R., Coffman, B. L., Ratain, M. J. (1998). Genetic predisposition to the metabolism of irinotecan (CPT-11). Role of uridine diphosphate glucuronosyltransferase isoform 1A1 in the glucuronidation of its active metabolite (SN-38) in human liver microsomes.J. Clin. Invest. 101:847–854. [PUBMED], [INFOTRIEVE], [CSA]
  • Iyer, L., Hall, D., Das, S., Mortell, M. A., Ramirez, J., Kim, S., Di Rienzo, A., Ratain, M. J. (1999). Phenotype-genotype correlation of in vitro SN-38 (active metabolite of irinotecan) and bilirubin glucuronidation in human liver tissue with UGT1A1 promoter polymorphism.Clin. Pharmacol. Ther. 65:576–582. [PUBMED], [INFOTRIEVE], [CSA]
  • Iyer, L., Das, S., Janisch, L., Wen, M., Ramirez, J., Karrison, T., Fleming, G. F., Vokes, E. E., Schilsky, R. L., Ratain, M. J. (2002). UGT1A1*28 polymorphism as a determinant of irinotecan disposition and toxicity.Pharmacogenomics J. 2:43–47. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Jacquet, M., Lambert, V., Baudoux, E., Muller, M., Kremers, P., Gielen, J. (1996). Correlation between P450 CYP1A1 inducibility, MspI genotype and lung cancer incidence.Eur. J. Cancer 32A:1701–1706. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Jansen, P. L., Bosma, P. J., Chowdury, J. R. (1995). Molecular biology of bilirubin metabolism.Prog. Liver Dis. 13:125–150. [PUBMED], [INFOTRIEVE], [CSA]
  • Jounaidi, Y., Hyrailles, V., Gervot, L., Maurel, P. (1996). Detection of CYP3A5 allelic variant: a candidate for the polymorphic expression of the protein?Biochem. Biophys. Res. Commun. 221:466–470. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Kadlubar, F. F., Berkowitz, G. S., Delongchamp, R. R., Wang, C., Green, B. L., Tang, G., Lamba, J., Schuetz, E., Wolff, M. S. (2003). The CYP3A4*1B variant is related to the onset of puberty, a known risk factor for the development of breast cancer.Cancer Epidemiol. Biomark. Prev. 12:327–331. [CSA]
  • Kaminsky, L. S., Zhang, Z. Y. (1997). Human P450 metabolism of warfarin.Pharmacol. Ther. 73:67–74. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Kao, S. Y., Wu, C. H., Lin, S. C., Yap, S. K., Chang, C. S., Wong, Y. K., Chi, L. Y., Liu, T. Y. (2002). Genetic polymorphism of cytochrome P4501A1 and susceptibility to oral squamous cell carcinoma and oral precancer lesions associated with smoking/betel use.J. Oral Pathol Med. 31:505–511. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Kaplan, M., Hammerman, C., Rubaltelli, F. F., Vilei, M. T., Levy-Lahad, E., Renbaum, P., Vreman, H. J., Stevenson, D. K., Muraca, M. (2002). Hemolysis and bilirubin conjugation in association with UDP-glucuronosyltransferase 1A1 promoter polymorphism.Hepatology 35:905–911. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Kariya, S., Isozaki, S., Uchino, K., Suzuki, T., Narimatsu, S. (1996). Oxidative metabolism of flunarizine and cinnarizine by microsomes from B-lymphoblastoid cell lines expressing human cytochrome P450 enzymes.Biol. Pharm. Bull. 19:1511–1514. [PUBMED], [INFOTRIEVE], [CSA]
  • Kawajiri, K., Nakachi, K., Imai, K., Yoshii, A., Shinoda, N., Watanabe, J. (1990). Identification of genetically high risk individuals to lung cancer by DNA polymorphism of the cytochrome P450IA1 gene.FEBS Lett. 263:131–133. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Kawajiri, K., Watanabe, J., Eguchi, H., Hayashi, S. (1995). Genetic polymorphisms of drug metabolising enzymes and lung cancer susceptibility.Pharmacogenetics 5:S70–S73. [PUBMED], [INFOTRIEVE]
  • Kham, S. K., Tan, P. L., Tay, A. H., Heng, C. K., Yeoh, A. E., Quah, T. C. (2002). Thiopurine methyltransferase polymorphisms in a multiracial asian population and children with acute lymphoblastic leukemia.J. Pediatr. Hematol./Oncol. 24:353–359., [CROSSREF]
  • Kharasch, E. D., Hoffer, C., Walker, A., Sheffels, P. (2003). Disposition and miotic effects of oral alfentanil: a potential noninvasive probe for first-pass cytochrome P4503A activity.Clin. Pharmacol. Ther. 73:199–208. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Kim, R. B., Leake, B. F., Choo, E. F., Dresser, G. K., Kubba, S. V., Schwarz, U. I., Taylor, A., Xie, H. G., McKinsey, J., Zhou, S., Lan, L. B., Schuetz, J. D., Schuetz, E. G., Wilkinson, G. R. (2001). Identification of functionally variant MDR1 alleles among European Americans and African Americans.Clin. Pharmacol. Ther. 70:189–199. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Kim, Y. H., Yeon, J. E., Jung, G. M., Kim, H. J., Kim, J. S., Byun, K. S., Bak, Y. T., Lee, C. H. (2002). [A study of polymorphism in UDP-glucuronosyltransferase 1 (UGT-1A1) promoter gene in Korean patients with Gilbert's syndrome].Taehan. Kan. Hakhoe. Chi. 8:132–138. [PUBMED], [INFOTRIEVE], [CSA]
  • King, B. P., Leathart, J. B., Mutch, E., Williams, F. M., Daly, A. K. (2003). CYP3A5 phenotype-genotype correlations in a British population.Br. J. Clin. Pharmacol. 55:625–629. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Kiso, S., Cai, S. H., Kitaichi, K., Furui, N., Takagi, K., Nabeshima, T., Hasegawa, T. (2000). Inhibitory effect of erythromycin on P-glycoprotein-mediated biliary excretion of doxorubicin in rats.Anticancer Res. 20:2827–2834. [PUBMED], [INFOTRIEVE], [CSA]
  • Kittles, R. A., Chen, W., Panguluri, R. K., Ahaghotu, C., Jackson, A., Adebamowo, C. A., Griffin, R., Williams, T., Ukoli, F., Adams-Campbell, L., Kwagyan, J., Isaacs, W., Freeman, V., Dunston, G. M. (2002). CYP3A4-V and prostate cancer in African Americans: causal or confounding association because of population stratification?Hum. Genet. 110:553–560. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Kliewer, S. A., Moore, J. T., Wade, L., Staudinger, J. L., Watson, M. A., Jones, S. A., McKee, D. D., Oliver, B. B., Willson, T. M., Zetterstrom, R. H., Perlmann, T., Lehmann, J. M. (1998). An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway.Cell 92:73–82. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Kohle, C., Mohrle, B., Munzel, P. A., Schwab, M., Wernet, D., Badary, O. A., Bock, K. W. (2003). Frequent co-occurrence of the TATA box mutation associated with Gilbert's syndrome (UGT1A1*28) with other polymorphisms of the UDP-glucuronosyltransferase-1 locus (UGT1A6*2 and UGT1A7*3) in Caucasians and Egyptians.Biochem. Pharmacol. 65:1521–1527. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Koiwai, O., Nishizawa, M., Hasada, K., Aono, S., Adachi, Y., Mamiya, N., Sato, H. (1995). Gilberts syndrome is caused by a heterozygous missense mutation in the gene for bilirubin UDP-glucuronosyltransferase.Hum. Mol. Genet. 4:1183–1186. [PUBMED], [INFOTRIEVE], [CSA]
  • Koiwai, O., Aono, S., Adachi, Y., Kamisako, T., Yasui, Y., Nishizawa, M., Sato, H. (1996). Grigler-Najjar syndrome type II is inherited both as a dominant and a recessive trait.Hum. Mol. Genet. 5:645–647. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Koizumi, A., Nomiyama, T., Tsukada, M., Wada, Y., Omae, K., Tanaka, S., Miyauchi, H., Imamiya, S., Sakurai, H. (1998). Evidence on N-acetyltransferase allele-associated metabolism of hydrazine in Japanese workers.J. Occup. Environ. Med. 40:217–222. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Komori, M., Nishio, K., Kitada, M., Shiramatsu, K., Muroya, K., Soma, M., Nagashima, K., Kamataki, T. (1990). Fetus-specific expression of a form of cytochrome P-450 in human livers.Biochemistry 29:4430–4433. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Kotekar, A., Bhisey, R. (2000). CYP1A1*2 and CYP1A1*3 polymorphisms cosegregate in the Indian population.Anthropol. Anz. 60:255–260. [CSA]
  • Krajinovic, M., Labuda, D., Richer, C., Karimi, S., Sinnett, D. (1999). Susceptibility to childhood acute lymphoblastic leukemia: influence of CYP1A1, CYP2D6, GSTM1, and GSTT1 genetic polymorphisms.Blood 93:1496–1501. [PUBMED], [INFOTRIEVE], [CSA]
  • Kristensen, V. N., Kure, E. H., Erikstein, B., Harada, N., Borresen-Dale, A. (2001). Genetic susceptibility and environmental estrogen-like compounds.Mutat. Res. 482:77–82. [PUBMED], [INFOTRIEVE]
  • Krynetskaia, N. F., Cai, X., Nitiss, J. L., Krynetski, E. Y., Relling, M. V. (2000). Thioguanine substitution alters DNA cleavage mediated by topoisomerase II.FASEB J. 14:2339–2344. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Krynetski, E. Y., Evans, W. E. (1999). Pharmacogenetics as a molecular basis for individualized drug therapy: the thiopurine S-methyltransferase paradigm.Pharm. Res. 16:342–349., [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Krynetski, E. Y., Evans, W. E. (2000). Genetic polymorphism of thiopurine S-methyltransferase: molecular mechanisms and clinical importance.Pharmacology, 61:136–146. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Krynetski, E. Y., Krynetskaia, N. F., Yanishevski, Y., Evans, W. E. (1995). Methylation of mercaptopurine, thioguanine, and their nucleotide metabolites by heterologously expressed human thiopurine S-methyltransferase.Mol. Pharmacol. 47:1141–1147. [PUBMED], [INFOTRIEVE], [CSA]
  • Krynetski, E. Y., Tai, H. L., Yates, C. R., Fessing, M. Y., Loennechen, T., Schuetz, J. D., Relling, M. V., Evans, W. E. (1996a). Genetic polymorphism of thiopurine S-methyltransferase: clinical importance and molecular mechanisms.Pharmacogenetics 6:279–290. [PUBMED], [INFOTRIEVE], [CSA]
  • Krynetski, E. Y., Tai, H. L., Yates, C. R., Fessing, M. Y., Loennechen, T., Schuetz, J. D., Relling, M. V., Evans, W. E. (1996b). Genetic-polymorphism of thiopurine S-methyltransferase. Clinical importance and molecular mechanisms.Pharmacogenetics 6:279–290. [PUBMED], [INFOTRIEVE], [CSA]
  • Kudoh, S., Fujiwara, Y., Takada, Y., Yamamoto, H., Kinoshita, A., Ariyoshi, Y., Furuse, K., Fukuoka, M. (1998). Phase II study of irinotecan combined with cisplatin in patients with previously untreated small-cell lung cancer. West Japan Lung Cancer Group.J. Clin. Oncol. 16:1068–1074. [PUBMED], [INFOTRIEVE]
  • Kuehl, P., Zhang, J., Lin, Y., Lamba, J., Assem, M., Schuetz, J., Watkins, P. B., Daly, A., Wrighton, S. A., Hall, S. D., Maurel, P., Relling, M., Brimer, C., Yasuda, K., Venkataramanan, R., Strom, S., Thummel, K., Boguski, M. S., Schuetz, E. (2001). Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression.Nat Genet. 27:383–391. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Kumar, A., Das, B. C., Shorma, J. K. (1994). BamHI restriction fragment length polymorphism (RFLP) at the human GST3 gene locus.Hum. Genet. 94:107–108. [PUBMED], [INFOTRIEVE]
  • Ladero, J. M., Agundez, J. A., Olivera, M., Lozano, L., Rodriguez-Lescure, A., Diaz-Rubio, M., Benitez, J. (2002). N-acetyltransferase 2 single-nucleotide polymorphisms and risk of gastric carcinoma.Eur. J. Clin. Pharmacol. 58:115–118. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Lafuente, A., Pujol, F., Carretero, P., Villa, J. P., Cuchi, A. (1993). Human glutathione S-transferase (GST mu) deficiency as a marker for the susceptibility to bladder and larynx cancer among smokers.Cancer Lett. 68:49–54. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Lai, J., Vesprini, D., Chu, W., Jernstrom, H., Narod, S. A. (2001). CYP gene polymorphisms and early menarche.Mol. Genet. Metab. 74:449–457. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Laing, N. M., Belinsky, M. G., Kruh, G. D., Bell, D. W., Boyd, J. T., Barone, L., Testa, J. R., Tew, K. D. (1998). Amplification of the ATP-binding cassette 2 transporter gene is functionally linked with enhanced efflux of estramustine in ovarian carcinoma cells.Cancer Res. 58:1332–1337. [PUBMED], [INFOTRIEVE]
  • Laisney, V., Gross, M. S., Frezal, J. (1984). Human genes for glutathione S-transferase.Hum. Genet. 68:221–227. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Lamba, J. K., Lin, Y. S., Schuetz, E. G., Thummel, K. E. (2002a). Genetic contribution to variable human CYP3A-mediated metabolism.Adv. Drug Deliv. Rev. 54:1271–1279. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Lamba, J. K., Lin, Y. S., Thummel, K., Daly, A., Watkins, P. B., Strom, S., Zhang, J., Schuetz, E. G. (2002b). Common allelic variants of cytochrome P4503A4 and their prevalence in different populations.Pharmacogenetics 12:121–132. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Lampe, J. W., Bigler, J., Horner, N. K., Potter, J. D. (1999). UDP-glucuronosyltransferase (UGT1A1*28 and UGT1A6*2) polymorphisms in Caucasians and Asians: relationships to serum bilirubin concentrations.Pharmacogenetics 9:341–349. [PUBMED], [INFOTRIEVE], [CSA]
  • Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., Devon, K., Dewar, K., Doyle, M., FitzHugh, W., Funke, R., Gage, D., Harris, K., Heaford, A., Howland, J., Kann, L., Lehoczky, J., LeVine, R., McEwan, P., McKernan, K., Meldrim, J., Mesirov, J. P., Miranda, C., Morris, W., Naylor, J. (2001). Initial sequencing and analysis of the human genome.Nature 409:860–921. [PUBMED], [INFOTRIEVE]
  • Landi, M. T., Bertazzi, P. A., Shields, P. G., Clark, G., Lucier, G. W., Garte, S. J., Cosma, G., Caporaso, N. E. (1994). Association between CYP1A1 genotype, mRNA expression and enzymatic activity in humans.Pharmacogenetics 4:242–246. [CSA]
  • Layton, D. W., Bogen, K. T., Knize, K. G., Hatch, F. T., Johnson, V. M., Felton, J. S. (1995). Cancer risk of heterocyclic amines in cooked foods: an analysis and implications for research.Carcinogenesis 16:39–52. [PUBMED], [INFOTRIEVE], [CSA]
  • Le Marchand, L., Sivaraman, L., Pierce, L., Seifried, A., Lum, A., Wilkens, L. R., Lau, A. F. (1998). Associations of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens.Cancer Res. 58:4858–4863. [PUBMED], [INFOTRIEVE]
  • Lee, E. J., Zhao, B., Moochhala, S. M., Ngoi, S. S. (1994). Frequency of mutant CYP1A1, NAT2 and GSTM1 alleles in a normal Chinese population.Pharmacogenetics 4:355–358. [PUBMED], [INFOTRIEVE], [CSA]
  • Lehmann, J. M., McKee, D. D., Watson, M. A., Willson, T. M., Moore, J. T., Kliewer, S. A. (1998). The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions.J. Clin. Invest. 102:1016–1023. [PUBMED], [INFOTRIEVE], [CSA]
  • Lemos, M. C., Regateiro, F. J. (1998). N-acetyltransferase genotypes in the Portuguese population.Pharmacogenetics 8:561–564. [PUBMED], [INFOTRIEVE], [CSA]
  • Lennard, L., Lilleyman, J. S. (1989). Variable mercaptopurine metabolism and treatment outcome in childhood lymphoblastic leukemia.J. Clin. Oncol. 7:1816–1823. [PUBMED], [INFOTRIEVE]
  • Lennard, L., van Loon, J. A., Weinshilboum, R. M. (1989). Pharmacogenetics of acute azathioprine toxicity: relationship to thiopurine methyltransferase genetic polymorphism.Clin. Pharmacol. Ther. 46:149–154. [PUBMED], [INFOTRIEVE], [CSA]
  • Lennard, L., Lilleyman, J. S., van Loon, J., Weinshilboum, R. M. (1990). Genetic variation in response to 6-mercaptopurine for childhood acute leukaemia.Lancet 336:225–229. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Lennard, L., Gibson, B. E., Nicole, T., Lilleyman, J. S. (1993). Congenital thiopurine methyltransferase deficiency and 6-mercaptopurine toxicity during treatment for acute lymphoblastic leukaemia.Arch. Dis. Child. 69:577–579. [PUBMED], [INFOTRIEVE]
  • Lennard, L., Welch, J. C., Lilleyman, J. S. (1997). Thiopurine drugs in the treatment of childhood leukaemia: the influence of inherited thiopurine methyltransferase activity on drug metabolism and cytotoxicity.Br. J. Clin. Pharmacol. 44:456–461. [CROSSREF]
  • Lin, J. H., Lu, A. Y. H. (1997). Role of pharmacokinetics and metabolism in drug discovery and development.Pharmacol. Rev. 49:403–449. [PUBMED], [INFOTRIEVE]
  • Lin, H. J., Han, C. Y., Lin, B. K., Hardy, S. (1993). Slow acetylator mutations in the human polymorphic N-acetyltransferase gene in 786 Asians, Blacks, Hispanics, and Whites: application to metabolic epidemiology.Am. J. Hum. Genet. 52:827–834. [PUBMED], [INFOTRIEVE], [CSA]
  • Lin, H. J., Han, C. Y., Lin, B. K., Hardy, S. (1994). Ethnic distribution of slow acetylator mutations in the polymorphic N-acetyltransferase (NAT2) gene.Pharmacogenetics 4:125–134. [PUBMED], [INFOTRIEVE], [CSA]
  • Lin, P., Wang, S. L., Wang, H. J., Chen, K. W., Lee, H. S., Tsai, K. J., Chen, C. Y., Lee, H. (2000). Association of CYP1A1 and microsomal epoxide hydrolase polymorphisms with lung squamous cell carcinoma.Br. J. Cancer. 82:852–857. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Lin, Y. S., Dowling, A. L., Quigley, S. D., Farin, F. M., Zhang, J., Lamba, J., Schuetz, E. G., Thummel, K. E. (2002). Co-regulation of CYP3A4 and CYP3A5 and contribution to hepatic and intestinal midazolam metabolism.Mol. Pharmacol. 62:162–172. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Liu, T. C., Lin, S. F., Chen, T. P., Chang, J. G. (2002). Polymorphism analysis of CYP3A5 in myeloid leukemia.Oncol. Rep. 9:327–329. [PUBMED], [INFOTRIEVE], [CSA]
  • Loennechen, T., Yates, C. R., Fessing, M. Y., Relling, M. V., Krynetski, E. Y., Evans, W. E. (1998). Isolation of a human thiopurine S-methyltransferase (TPMT) complementary DNA with a single nucleotide transition A719G (TPMT*3C) and its association with loss of TPMT protein and catalytic activity in humans.Clin. Pharmacol. Ther. 64:46–51. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Loennechen, T., Utsi, E., Hartz, I., Lysaa, R., Kildalsen, H., Aarbakke, J. (2001). Detection of one single mutation predicts thiopurine S-methyltransferase activity in a population of Saami in northern Norway.Clin. Pharmacol. Ther. 70:183–188., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • London, S. J., Yuan, J. M., Coetzee, G. A., Gao, Y. T., Ross, R. K., Yu, M. C. (2000). CYP1A1 I462V genetic polymorphism and lung cancer risk in a cohort of men in Shanghai, China.Cancer Epidemiol. Biomark. Prev. 9:987–991. [CSA]
  • Longuemaux, S., Delomenie, C., Gallou, C., Mejean, A., Vincent-Viry, M., Bouvier, R., Droz, D., Krishnamoorthy, R., Galteau, M. M., Junien, C., Beroud, C., Dupret, J. M. (1999). Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.Cancer Res. 59:2903–2908. [PUBMED], [INFOTRIEVE]
  • Loo, T. W., Clarke, D. M. (1994). Functional consequences of glycine mutations in the predicted cytoplasmic loops of P-glycoprotein.J. Biol. Chem. 269:7243–7248. [PUBMED], [INFOTRIEVE]
  • MacKenzie, P. I., Owens, I. S., Burchell, B., Bock, K. W., Bairoch, A., Belanger, A., Fournel-Gigleux, S., Green, M., Hum, D. W., Iyanagi, T., Lancet, D., Louisot, P., Magdalou, J., Chowdhury, J. R., Ritter, J. K., Schachter, H., Tephly, T. R., Tipton, K. F., Nebert, D. W. (1997). The, UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence.Pharmacogenetics 7:255–269. [PUBMED], [INFOTRIEVE], [CSA]
  • Mackenzie, P. I., Miners, J. O., McKinnon, R. A. (2000). Polymorphisms in UDP glucuronosyltransferase genes: functional consequences and clinical relevance.Clin. Chem. Lab. Med. 38:889–892. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Manabe, S., Tohyama, K., Wada, O., Aramaki, T. (1991). Detection of a carcinogen, 2-amino-1methyl-6-phenylimidazo [4:5 -b]pyridine (PhIP) in cigarette smoke condensate.Carcinogenesis 12:1945–1947. [PUBMED], [INFOTRIEVE], [CSA]
  • Marinaki, A. M., Arenas, M., Khan, Z. H., Lewis, C. M., Escuredo, E., Fairbanks, L. D., Mayberry, J. F., Wicks, A. C., Ansari, A., Sanderson, J., Duley, J. A. (2003). Genetic determinants of the thiopurine methyltransferase intermediate activity phenotype in British Asians and Caucasians.Pharmacogenetics 13:97–105. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Martin, A. M., Weber, B. L. (2000). Genetic and hormonal risk factors in breast cancer.J. Natl. Cancer Inst. 92:1126–1135. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Masubuchi, Y., Narimatsu, S., Hosokawa, S., Suzuki, T. (1994). Role of the CYP2D subfamily in metabolism-dependent covalent binding of propranolol to liver microsomal protein in rats.Biochem. Pharmacol. 48:1891–1898. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Matsus, N., Thygesen, P., Stacey, M., Risch, A., Sim, E. (1997). Mapping AAC1, AAC2 and AACP, the genes for arylamine N-acetyltransferases, carcinogen metabolising enzymes on human chromosome 8p22, a region frequently deleted in tumours.Cytogenet. Cell Genet. 77:290–295. [CSA]
  • Mayer, U., Wagenaar, E., Dorobek, B., Beijnen, J. H., Borst, P., Schinkel, A. H. (1997). Full blockade of intestinal P-glycoprotein and extensive inhibition of blood-brain barrier P-glycoprotein by oral treatment of mice with PSC833.J. Clin. Invest. 100:2430–2436. [PUBMED], [INFOTRIEVE], [CSA]
  • McLeod, H. L. (2001). Pharmacogenetics: more than skin deep.Nat. Genet. 29:247–248. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • McLeod, H. L., Evans, W. E. (2001). Pharmacogenomics: unlocking the human genome for better drug therapy.Annu. Rev. Pharmacol. Toxicol. 41:101–121. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • McLeod, H. L., Siva, C. (2002). The thiopurine S-methyltransferase gene locus–implications for clinical pharmacogenomics.Pharmacogenomics 3:89–98. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • McLeod, H. L., Lin, J. S., Scott, E. P., Pui, C. H., Evans, W. E. (1994). Thiopurine methyltransferase activity in American white subjects and black subjects.Clin. Pharmacol. Ther. 55:15–20. [PUBMED], [INFOTRIEVE], [CSA]
  • McLeod, H. L., Pritchard, S. C., Githang'a, J., Indalo, A., Ameyaw, M. M., Powrie, R. H., Booth, L., Collie-Duguid, E. S. (1999). Ethnic differences in thiopurine methyltransferase pharmacogenetics: evidence for allele specificity in Caucasian and Kenyan individuals.Pharmacogenetics 9:773–776. [PUBMED], [INFOTRIEVE], [CSA]
  • Meisel, P. (2002). Arylamine N-acetyltransferases and drug response.Pharmacogenomics 3:349–366., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Meyer, U. A., Zanger, U. M. (1997). Molecular mechanisms of genetic polymorphisms of drug metabolism.Annu. Rev. Pharmacol. Toxicol. 37:269–296. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Micka, J., Milatovich, A., Menon, A., Grabowski, G. A., Puga, A., Nebert, D. W. (1997). Human Ah receptor (AHR) gene: localization to 7p15 and suggestive correlation of polymorphism with CYP1A1 inducibility.Pharmacogenetics 7:95–101. [PUBMED], [INFOTRIEVE], [CSA]
  • Mickley, L. A., Lee, J. S., Weng, Z., Zhan, Z., Alvarez, M., Wilson, W., Bates, S. E., Fojo, T. (1998). Genetic polymorphisms in MDR-1: a tool for examining allelic expression in normal cells, unselected and drug-selected cell lines and human tumours.Blood 91:1749–1756. [PUBMED], [INFOTRIEVE], [CSA]
  • Min, D. I., Ellingrod, V. L. (2003). Association of the CYP3A4*1B 5′-flanking region polymorphism with cyclosporine pharmacokinetics in healthy subjects.Ther. Drug Monit. 25:305–309. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Miners, J. O., McKinnon, R. A., Mackenzie, P. I. (2002). Genetic polymorphisms of UDP-glucuronosyltransferases and their functional significance.Toxicology 27:453–456. [CROSSREF]
  • Mitchell, J. R., Thorgeirsson, U. P., Black, M., Timbrell, J. A., Snodgrass, W. R., Potter, W. Z., Jollow, H. R., Keiser, H. R. (1975). Increased incidence of isoniazid hepatitis in rapid acetylators: possible relation to hydranize metabolites.Clin. Pharmacol. Ther. 18:70–79. [PUBMED], [INFOTRIEVE]
  • Miyata, M., Tamura, E., Motoki, K., Nagata, K., Yamazoe, Y. (2003). Thalidomide-induced suppression of embryo fibroblast proliferation requires CYP1A1-mediated activation.Drug Metab. Dispos. 31:469–475. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Miyoshi, Y., Takahashi, Y., Egawa, C., Noguchi, S. (2002). Breast cancer risk associated with CYP1A1 genetic polymorphisms in Japanese women.Breast J. 8:209–215. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Monaghan, G., Ryan, M., Seddon, R., Hume, R., Burchell, B. (1996). Genetic variation in bilirubin UDP-glucuronosyltransferase gene promoter and Gilbert's syndrome.Lancet 347:578–581. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Monaghan, G., Foster, B., Jurima-Romet, M., Hume, R., Burchell, B. (1997). UGT1*1 genotyping in a Canadian Inuit population.Pharmacogenetics 7:153–156. [PUBMED], [INFOTRIEVE], [CSA]
  • Murata, M., Watanabe, M., Yamanaka, M., Kubota, Y., Ito, H., Nagao, M., Katoh, T., Kamataki, T., Kawamura, J., Yatani, R., Shiraishi, T. (2001). Genetic polymorphisms in cytochrome P450 (CYP) 1A1, CYP1A2, CYP2E1, glutathione S-transferase (GST) M1 and GSTT1 and susceptibility to prostate cancer in the Japanese population.Cancer Lett. 165:171–177. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Naoe, T., Takeyama, K., Yokozawa, T., Kiyoi, H., Seto, M., Uike, N., Ino, T., Utsunomiya, A., Maruta, A., Jin-nai, I., Kamada, N., Kubota, Y., Nakamura, H., Shimazaki, C., Horiike, S., Kodera, Y., Saito, H., Ueda, R., Wiemels, J., Ohno, R. (2000). Analysis of genetic polymorphism in NQO1, GST-M1, GST-T1, and CYP3A4 in 469 Japanese patients with therapy-related leukemia/myelodysplastic syndrome and de novo acute myeloid leukemia.Clin Cancer Res. 6:4091–4095. [PUBMED], [INFOTRIEVE], [CSA]
  • Nazar-Stewart, V., Motulsky, A. G., Eaton, D. L., White, E., Hornung, S. K., Leng, Z. T., Stapleton, P., Weiss, N. S. (1993). The glutathione S-transferase polymorphism as a marker for the susceptibility to lung carcinoma.Cancer Res. 53:2313–2318. [PUBMED], [INFOTRIEVE]
  • Nelson, D. R., Koymans, L., Kamataki, T., Stegeman, J. J., Feyereisen, R., Waxman, D. J., Waterman, M. R., Gotoh, O., Coon, M. J., Estabrook, R. W., Gunsalus, I. C., Nebert, D. W. (1996). P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature.Pharmacogenetics, 6:1–42. [PUBMED], [INFOTRIEVE], [CSA]
  • Ohno, M., Yamaguchi, I., Yamamoto, I., Fukuda, T., Yokota, S., Maekura, R., Ito, M., Yamamoto, Y., Ogura, T., Maeda, K., Komuta, K., Igarashi, T., Azumam, J. (2000). Slow N-acetyltransferase 2 genotype affects the incidence of isoniazid and rifampicin-induced hepatotoxicity.Int. J. Tuberc. Lung Dis. 4:256–261. [PUBMED], [INFOTRIEVE], [CSA]
  • Ohyama, K., Nakajima, M., Nakamura, S., Shimada, N., Yamazaki, H., Yokoi, T. (2000). A significant role of human cytochrome P4502C8 in amiodarone N-deethylation: an approach to predict the contribution with relative activity factor.Drug Metab. Dispos. 28:1303–1310. [PUBMED], [INFOTRIEVE], [CSA]
  • Okino, S. T., Quattrochi, L. C., Pendurthi, U. R., McBride, O. W., Tukey, R. H. (1987). Characterization of multiple human cytochrome P-450 1 cDNAs. The chromosomallocalization of the gene and evidence for alternate RNA splicing.J. Biol. Chem. 262:16072–16079. [PUBMED], [INFOTRIEVE]
  • Okkels, H., Sigsgaard, T., Wolf, H., Autrup, H. (1997). Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.Cancer Epidemiol. Biomark. Prev. 6:225–231. [CSA]
  • Ortiz de Montellano, P. R., Correia, M. A. (1995). Inhibition of cytochrome P450. In: Ortiz de Montellano, P. R., ed. Cytochrome P450: Structure, Mechanism and Biochemistry. New York: Plenum Press, pp. 305–366.
  • Otterness, D., Szumlanski, C., Lennard, L., Klemetsdal, B., Aarbakke, J., Park-Hah, J. O., Iven, H., Schmiegelow, K., Branum, E., O'Brien, J., Weinshilboum, R. (1997). Human thiopurine methyltransferase pharmacogenetics: gene sequence polymorphisms.Clin. Pharmacol. Ther. 62:60–73. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Otterness, D. M., Szumlanski, C. L., Wood, T. C., Weinshilboum, R. M. (1998). Human thiopurine methyltransferase pharmacogenetics. Kindred with a terminal exon splice junction mutation that results in loss of activity.J. Clin. Invest. 101:1036–1044. [PUBMED], [INFOTRIEVE], [CSA]
  • Ozawa, S., Abu-Zeid, M., Kawakubo, Y., Toyama, S., Yamazoe, Y., Kato, R. (1990). Monomorphic and polymorphic isozymesof arylamine N-acetyltransferases in hamster liver: purification of the isozymes and genetic basis of N-acetylation polymorphism.Carcinogenesis 11:2137–2144. [PUBMED], [INFOTRIEVE]
  • Paris, P. L., Kupelian, P. A., Hall, J. M., Williams, T. L., Levin, H., Klein, E. A., Casey, G., Witte, J. S. (1999). Association between a CYP3A4 genetic variant and clinical presentation in African-American prostate cancer patients.Cancer Epidemiol. Biomark. Prev. 8:901–905. [CSA]
  • Patki, K. C., Von Moltke, L. L., Greenblatt, D. J. (2003). In vitro metabolism of midazolam, triazolam, nifedipine, and testosterone by human liver microsomes and recombinant cytochromes P450: role of CYP3A4 and CYP3A5.Drug Metab. Dispos. 31:938–944. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Paulussen, A., Lavrijsen, K., Bohets, H., Hendrickx, J., Verhasselt, P., Luyten, W., Konings, F., Armstrong, M. (2000). Two linked mutations in transcriptional regulatory elements of the CYP3A5 gene constitute the major genetic determinant of polymorphic activity in humans.Pharmacogenetics 10:415–424. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Pearson, W. R., Vorachek, W. R., Xu, S. J., Berger, R., Hart, I., Vannais, D., Patterson, D. (1993). Identification of class-mu glutathione S-transferase genes GSTM1-GSTM5 on chromosome 1p13.Am. J. Hum. Genet. 53:220–233. [PUBMED], [INFOTRIEVE], [CSA]
  • Pelkonen, O., Nebert, D. W. (1982). Metabolism of polycyclic aromatic hydrocarbons: etiologic role in carcinogenesis.Pharmacol. Rev. 34:189–222. [PUBMED], [INFOTRIEVE]
  • Pemble, S., Scroeder, K. R., Spencer, S. R., Meyer, D. J., Hallier, E., Bolt, H. M., Ketterer, B., Taylor, J. B. (1994). Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterisation of a genetic polymorphism.Biochem. J. 300:271–276. [PUBMED], [INFOTRIEVE], [CSA]
  • Persson, I., Johansson, I., Lou, Y. C., Yue, Q. Y., Duan, L. S., Bertilsson, L., Ingelman-Sundberg, M. (1999). Genetic polymorphism of xenobiotic metabolizing enzymes among Chinese lung cancer patients.Int. J. Cancer, 81:325–329. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Peters, J. H., Murray, J. F. Jr, Gordon, G. R., Levy, L., Russell, D. A., Scott, G. C., Vincin, D. R., Shepard, C. C. (1977). Acedapsone treatment of leprosy patients: response versus drug disposition.Am. J. Trop. Med. Hyg. 26:127–136. [PUBMED], [INFOTRIEVE]
  • Petersen, D. D., McKinney, C. E., Ikeya, K., Smith, H. H., Bale, A. E., McBride, O. W., Nebert, D. W. (1991). Human CYP1A1 gene: cosegregation of the enzyme inducibility phenotype and an RFLP.Am. J. Hum. Genet. 48:720–725. [PUBMED], [INFOTRIEVE], [CSA]
  • Postlind, H., Vu, T. P., Tukey, R. H., Quattrochi, L. C. (1993). Response of human CYP1-luciferase plasmids to. 2,3,7,8-tetrachlorodibenzo-p-dioxin and polycyclic aromatic hydrocarbons.Toxicol. Appl. Pharmacol. 118:255–262. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Quattrochi, L. C., Guzelian, P. S. (2001). CYP3A regulation: from pharmacology to nuclear receptors.Drug Metab. Dispos. 29:615–622., [PUBMED], [INFOTRIEVE], [CSA]
  • Radominska-Pandya, A., Czernik, P. J., Little, J. M., Battaglia, E., Mackenzie, P. I. (1999). Structural and functional studies of UDP-glucuronosyltransferases.Drug Metab. Rev. 31:817–899. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Rebbeck, T. R., Jaffe, J. M., Walker, A. H., Wein, A. J., Malkowicz, S. B. (1998). Modification of clinical presentation of prostate tumours by a novel genetic variant in CYP3A4.J. Natl. Cancer Inst. 90:1225–1229. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Relling, M. V., Hancock, M. L., Boyett, J. M., Evans, Pui, C.-H. (1999). Prognostic importance of 6-mercaptopurine dose intensity in acute lymphoblastic leukemia.Blood 93:2817–2823. [PUBMED], [INFOTRIEVE], [CSA]
  • Rendic, S. (2002). Summary of information on human CYP enzymes: human P450 metabolism data.Drug Metab. Rev. 34:83–448. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Rendic, S., Di Carlo, F. J. (1997). Human cytochrome P450 enzyme: a status report summarizing their reactions, substrates, induction, and inhibitors.Drug Metab. Rev. 29:413–580. [PUBMED], [INFOTRIEVE], [CSA]
  • Rivory, L. P., Bowles, M. R., Robert, J., Pond, S. M. (1996a). Conversion of irinotecan (CPT-11) to its active metabolite, 7-ethyl-10-hydroxycamptothecin (SN-38), by human liver carboxylesterase.Biochem. Pharmacol. 52:1103–1111. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Rivory, L. P., Riou, J. F., Haaz, M. C., Sable, S., Vuilhorgne, M., Commercon, A., Pond, S. M., Robert, J. (1996b). Identification and properties of a major plasma metabolite of irinotecan (CPT-11) isolated from the plasma of patients.Cancer Res. 56:3689–3694. [PUBMED], [INFOTRIEVE]
  • Ross, V. L., Board, P. G., Webb, G. C. (1993). Chromosomal mapping of the human mu class glutathione S-transferases to 1p13.Genomics 18:87–91. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Ross, R. K., Pike, M. C., Coetzee, G. A., Reichardt, J. K., Yu, M. C., Feigelson, H., Stanczyk, F. Z., Kolonel, L. N., Henderson, B. E. (1998). Androgen metabolism and prostate cancer: establishing a model of genetic susceptibility.Cancer Res. 58:4497–4504. [PUBMED], [INFOTRIEVE]
  • Rossi, A. M., Bianchi, M., Guarnieri, C., Barale, R., Pacifici, G. M. (2001). Genotype-phenotype correlation for thiopurine S-methyltransferase in healthy Italian subjects.Eur. J. Clin. Pharmacol. 57:51–54. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Rothman, N., Hayes, R. B., Bi, W., Caporaso, N., Broly, F., Woosley, R. L., Yin, S., Feng, P., You, X., Meyer, U. A. (1993). Correlation between N-acetyltransferase activity and NAT2 genotype in Chinese males.Pharmacogenetics 3:250–255. [PUBMED], [INFOTRIEVE], [CSA]
  • Saeki, M., Saito, Y., Nakamura, T., Murayama, N., Kim, S. R., Ozawa, S., Komamura, K., Ueno, K., Kamakura, S., Nakajima, T., Saito, H., Kitamura, Y., Kamatani, N., Sawa, J. (2003). Single nucleotide polymorphisms and haplotype frequencies of CYP3A5 in a Japanese population.Hum Mutat. 21:653–659. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Sakaeda, T., Nakamura, T., Horinouchi, M., Kakumoto, M., Ohmoto, N., Sakai, T., Morita, Y., Tamura, T., Aoyama, N., Hirai, M., Kasuga, M., Okumura, K. (2001). MDR1 genotype-related pharmacokinetics of digoxin after single oral administration in healthy Japanese subjects.Pharm. Res. 18:1400–1404. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Sata, F., Sapone, A., Elizondo, G., Stocker, P., Miller, V. P., Zheng, W., Raunio, H., Crespi, C. L., Gonzalez, F. J. (2000). CYP3A4 allelic variants with amino acid substitutions in exon 7 and 12: evidence for an allelic variant with altered catalytic activity.Clin. Pharmacol. Ther. 67:48–56. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Scherer, S. W., Rommens, J. M., Soder, S., Wong, E., Plavsic, N., Tompkins, B. J., Beattie, A., Kim, J., Tsui, L. C. (1993). Refined localisation and yeast artificial chromosome (YAC) contig-mapping of genes and DNA segments in the 7q21-q32 region.Hum. Mol. Genet. 2:751–760. [PUBMED], [INFOTRIEVE], [CSA]
  • Schinkel, A. H. (1998). Pharmacological insights from P-glycoprotein knockout mice.Int J Clin. Pharmacol. Ther. 36:9–13. [PUBMED], [INFOTRIEVE]
  • Schuetz, J. D., Guzelian, P. S. (1995). Isolation of CYP3A5P cDNA from human liver: a reflection of a novel cytochrome P-450 pseudogene.Biochim. Biophys. Acta 1261:161–165. [PUBMED], [INFOTRIEVE]
  • Schuetz, J. D., Beach, D. L., Guzelian, P. S. (1994). Selective expression of cytochrome P450 CYP3A mRNAs in embryonic and adult human liver.Pharmacogenetics 4:11–20., [PUBMED], [INFOTRIEVE], [CSA]
  • Seidegard, J., Ekstrom, G. (1997). The role of human glutathione transferases and epoxide hydrolases in the metabolism of xenobiotics.Environ. Health Perspect. 105:791–799. [PUBMED], [INFOTRIEVE]
  • Seow, A., Yuan, J. M., Sun, C. L., Van Den Berg, D., Lee, H. P., Yu, M. C. (2002). Dietary isothiocyanates, glutathione S-transferase polymorphisms and colorectal cancer risk in the Singapore Chinese Health Study.Carcinogenesis 23:2055–2061. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Seppen, J., Bosma, P. J., Goldhoorn, B. G., Bakker, C. T., Chowdury, J. R., Chowdhury, N. R., Jansen, P. L., Oude Elferink, R. P. (1994). Discrimination between Crigler-Najjar syndrome type I and II by expression of mutant bilirubin uridine diphosphate-glucuronosyltransferase.J. Clin. Invest. 94:2385–2391. [PUBMED], [INFOTRIEVE], [CSA]
  • Shapiro, A. B., Ling, V. (1998). Stoichiometry of coupling of rhodamine 123 transport to ATP hydrolysis by P-glycoprotein.Eur. J. Biochem. 254:189–193. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Sheehan, D., Meade, G., Foley, V. M., Dowd, C. A. (2001). Structure, function and evolution of glutathione transferases: implications for classification of non-mammalian members of an ancient enzyme superfamily.Biochem. J. 360:1–16. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Shih, P. S., Huang, J. D. (2002). Pharmacokinetics of midazolam and 1′-hydroxymidazolam in Chinese with different CYP3A5 genotypes.Drug Metab. Dispos. 30:1491–1496. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Shimada, T., Yun, C. H., Yamazaki, H., Gautier, J. C., Beaune, P. H., Guengerich, F. P. (1992). Characterization of human lung microsomal cytochrome P450 1A1 and its role in the oxidation of chemical carcinogens.Mol. Pharmacol. 41:856–864. [PUBMED], [INFOTRIEVE], [CSA]
  • Shimada, T., Yamazaki, H., Mimura, M., Inui, Y., Guengerich, F. P. (1994). Interindividual variations in human liver cytochrome P450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals.J. Pharmacol. Exp. Ther. 270:414–423. [PUBMED], [INFOTRIEVE], [CSA]
  • Shimada, T., Oda, Y., Gillam, E. M. J., Guengerich, F. P., Inoue, K. (2001). Metabolic activation of polycyclic aromatic hydrocarbons and other procarcinogens by cytochrome P450 1A1 and P450 1B1 allelic variants and other human cytochromes P450 in Salmonella typhimurium NM2009.Drug Metab. Dispos. 29:1176–1182. [PUBMED], [INFOTRIEVE], [CSA]
  • Shimada, T., Inoue, K., Suzuki, Y., Kawai, T., Azuma, E., Nakajima, T., Shindo, M., Kurose, K., Sugie, A., Yamagishi, Y., Fujii-Kuriyama, Y., Hashimoto, M. (2002). Arylhydrocarbon receptor-dependent induction of liver and lung cytochromes P450 1A1, 1A2, and 1B1 by polycyclic aromatic hydrocarbons and polychlorinated biphenyls in genetically engineered C57BL/6J mice.Carcinogenesis 23:1199–1207. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Siedegard, J., Vorachek, W. R., Pero, R. W., Pearson, W. R. (1988). Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion.Proc. Natl. Acad. Sci. U. S. A. 85:7293–7297. [CSA]
  • Silvestri, L., Sonzogni, L., De Silvestri, A., Gritti, C., Foti, L., Zavaglia, C., Leveri, M., Cividini, A., Mondelli, M. U., Civardi, E., Silini, E. M. (2003). CYP enzyme polymorphisms and susceptibility to HCV-related chronic liver disease and liver cancer.Int. J. Cancer 104:310–317. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Sivaraman, L., Leatham, M. P., Yee, J., Wilkens, L. R., Lau, A. F., Le Marchand, L. (1994). CYP1A1 genetic polymorphisms and in situ colorectal cancer.Cancer Res. 54:3692–3695. [PUBMED], [INFOTRIEVE]
  • Smart, J., Daly, A. K. (2000). Variation in induced CYP1A1 levels: relationship to CYP1A1, Ah receptor and GSTM1 polymorphisms.Pharmacogenetics 10:11–24. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Smith, C. A., Wadelius, M., Gough, A. C., Harrison, D. J., Wolf, C. R., Rane, A. (1997). A simplified assay for the arylamine N-acetyltransferase 2 polymorphism validated by phenotyping with isoniazid.J. Med. Genet. 34:758–760. [PUBMED], [INFOTRIEVE], [CSA]
  • Song, S., Suzuki, H., Kawai, R., Sugiyama, Y. (1999). Effect of PSC 833, a P-glycoprotein modulator, on the disposition of vincristine and digoxin in rats.Drug Metab. Dispos. 27:689–694. [PUBMED], [INFOTRIEVE], [CSA]
  • Song, N., Tan, W., Xing, D., Lin, D. (2001). CYP1A1 polymorphism and risk of lung cancer in relation to tobacco smoking: a case-control study in China.Carcinogenesis 22:11–16., [PUBMED], [INFOTRIEVE], [CSA]
  • Soyama, A., Hanioka, N., Saito, Y., Murayama, N., Ando, M., Ozawa, S., Sawada, J. (2002). Amiodarone N-deethylation by CYP2C8 and its variants.Pharmacol. Toxicol. 91:174–178. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Spire-Vayron de la Moureyre, C., Debuysere, H., Mastain, B., Vinner, E., Marez, D., Lo Guidice, J. M., Chevalier, D., Brique, S., Motte, K., Colombel, J. F., Turck, D., Noel, C., Flipo, R. M., Pol, A., Lhermitte, M., Lafitte, J. J., Libersa, C., Broly, F. (1998). Genotypic and phenotypic analysis of the polymorphic thiopurine S-methyltransferase gene (TPMT) in a European population.Br. J. Pharmacol. 125:879–887. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Spurdle, A. B., Goodwin, B., Hodgson, E., Hopper, J. L., Chen, X., Purdie, D. M., McCredie, M. R., Giles, G. G., Chenevix-Trench, G., Liddle, C. (2002). The CYP3A4*1B polymorphism has no functional significance and is not associated with risk of breast or ovarian cancer.Pharmacogenetics 12:355–366. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Spurr, N. K., Gough, A. C., Stevenson, K., Wolf, C. R. (1987). Msp-I polymophism detected with a cDNA probe for the P-450 I family on chromosome 15.Nucleic Acids Res. 15:5901. [PUBMED], [INFOTRIEVE]
  • Spurr, N. K., Gough, A. C., Stevenson, K., Wolf, C. R. (1989). The human cytochrome P450 CYP3A locus: assignment to chromosome 7q22-qter.Hum. Genet. 81:171–174. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Sreelekha, T. T., Ramadas, K., Pandey, M., Thomas, G., Nalinakumari, K. R., Pillai, M. R. (2001). Genetic polymorphism of CYP1A1, GSTM1 and GSTT1 genes in Indian oral cancer.Oral Oncol. 37:593–598. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Stanulla, M., Schrappe, M., Brechlin, A. M., Zimmermann, M., Welte, K. (2000). Polymorphisms within glutathione S-transferase genes (GSTM1, GSTT1, GSTP1) and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia: a case-control study.Blood 95:1222–1228. [PUBMED], [INFOTRIEVE], [CSA]
  • Strange, R. C., Faulder, C. G., Davis, B. A., Hume, R., Brown, J. A., Cotton, W., Hopkinson, D. A. (1984). The human glutathione S-transferases: studies on the tissue distribution and genetic variation of the GST1m, GST2 and GST3 isoenzymes.Ann. Hum. Genet. 48:11–20. [PUBMED], [INFOTRIEVE]
  • Strassburg, C. P., Strassburg, A., Nguyen, N., Li, Q., Manns, M. P., Tukey, R. H. (1999). Regulation and function of family 1 and family 2 UDP-glucuronosyltransferase genes (UGT1A, UGT2B) in human oesophagus.Biochem. J. 338:489–498. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Strassburg, C. P., Kneip, S., Topp, J., Obermayer-Straub, P., Barut, A., Tukey, R. H., Manns, M. P. (2000). Polymorphic gene regulation and interindividual variation of UDP-glucuronosyltransferase activity in human small intestine.J. Biol. Chem. 275:36164–36171. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Stucker, I., Jacquet, M., de Waziers, I., Cenee, S., Beaune, P., Kremers, P., Hemon, D. (2000). Relation between inducibility of CYP1A1, GSTM1 and lung cancer in a French population.Pharmacogenetics 10:617–627. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Sueyoshi, T., Negishi, M. (2001). Phenobarbital response elements of cytochrome P450 genes and nuclear receptors.Annu. Rev. Pharmacol. Toxicol. 41:123–143. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Suzuki, T., Johnston, P. N., Board, P. G. (1993). Structure and organization of the human alpha class glutathione S-transferase genes and related pseudogenes.Genomics 18:680–686. [PUBMED], [INFOTRIEVE], [CSA]
  • Suzuki, K., Matsui, H., Nakazato, H., Koike, H., Okugi, H., Hasumi, M., Ohtake, N., Nakata, S., Takei, T., Hatori, M., Ito, K., Yamanaka, H. (2003). Association of the genetic polymorphism in cytochrome P450 (CYP) 1A1 with risk of familial prostate cancer in a Japanese population: a case-control study.Cancer Lett. 195:177–183. [PUBMED], [INFOTRIEVE], [CSA]
  • Swanson, H. I., Bradfield, C. A. (1993). The Ah-receptor: genetics, structure and function.Pharmacogenetics, 3:213–230. [PUBMED], [INFOTRIEVE], [CSA]
  • Sweeney, C., McClure, G. Y., Fares, M. Y., Stone, A., Coles, B. F., Thompson, P. A., Korourian, S., Hutchins, L. F., Kadlubar, F. F., Ambrosone, C. B. (2000). Association between survival after treatment for breast cancer and glutathione S-transferase P1 Ile105Val polymorphism.Cancer Res. 60:5621–5624. [PUBMED], [INFOTRIEVE]
  • Tai, H. L., Krynetski, E. Y., Yates, C. R., Loennechen, T., Fessing, M. Y., Krynetskaia, N. F., Evans, W. E. (1996). Thiopurine S-methyltransferase deficiency: two nucleotide transitionsdefine the most prevalent mutant allele associated with loss of catalytic activity in Caucasians.Am. J. Hum. Genet. 58:694–702. [PUBMED], [INFOTRIEVE], [CSA]
  • Taioli, E., Trachman, J., Chen, X., Toniolo, P., Garte, S. J. (1995). A CYP1A1 restriction fragment polymorphism is associated with breast cancer in African–American women.Cancer Res. 55:3757–3758. [PUBMED], [INFOTRIEVE]
  • Taioli, E., Ford, J., Trachman, J., Li, Y., Demopoulos, R., Garte, S. (1998). Lung cancer risk and CYP1A1 genotype in African Americans.Carcinogenesis 19:813–817. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Tanabe, M., Ieiri, I., Nagata, N., Inoue, K., Ito, S., Kanamori, Y., Takahashi, M., Kurata, Y., Kigawa, J., Higuchi, S., Terakawa, N., Otsubo, K. (2001). Expression of P-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene.J. Pharmacol. Exp. Ther. 297:1137–1143. [PUBMED], [INFOTRIEVE], [CSA]
  • Tassaneeyakul, W., Birkett, D. J., Veronese, M. E., McManus, M. E., Tukey, R. H., Quattrochi, L. C., Gelboin, H. V., Miners, J. O. (1993). Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2.J. Pharmacol. Exp. Ther. 265:401–407. [PUBMED], [INFOTRIEVE]
  • Tateishi, T., Watanabe, M., Moriya, H., Yamaguchi, S., Sato, T., Kobayashi, S. (1999). No ethnic difference between Caucasian and Japanese hepatic samples in the expression frequency of CYP3A5 and CYP3A7 proteins.Biochem. Pharmacol. 57:935–939. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Tayeb, M. T., Clark, C., Ameyaw, M. M., Haites, N. E., Evans, D. A., Tariq, M., Mobarek, A., Ofori-Adjei, D., McLeod, H. L. (2000). CYP3A4 promoter variant in Saudi, Ghanaian and Scottish Caucasian populations.Pharmacogenetics 10:753–756. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Tayeb, M. T., Clark, C., Sharp, L., Haites, N. E., Rooney, P. H., Murray, G. I., Payne, S. N., McLeod, H. L. (2002). CYP3A4 promoter variant is associated with prostate cancer risk in men with benign prostate hyperplasia.Oncol. Rep. 9:653–655. [PUBMED], [INFOTRIEVE], [CSA]
  • Tefre, T., Ryberg, D., Haugen, A., Nebert, D. W., Skaug, V., Brogger, A., Borresen, A. L. (1991). Human CYP1A1 (cytochrome P450) gene: lack of association between the Msp I restriction fragment length polymorphism and incidence of lung cancer in a Norwegian population.Pharmacogenetics 1:20–25. [PUBMED], [INFOTRIEVE]
  • Terry, K. L., Titus-Ernstoff, L., Garner, E. O., Vitonis, A. F., Cramer, D. W. (2003). Interaction between CYP1A1 polymorphic variants and dietary exposures influencing ovarian cancer risk.Cancer Epidemiol. Biomark. Prev. 12:187–190.
  • Tew, K. D. (1994). Glutathione-associated enzymes in anticancer drug resistance.Cancer Res. 54:4313–4320. [PUBMED], [INFOTRIEVE]
  • Thorisson, G. A., Stein, L. D. (2003). The SNP Consortium website: past, present and future.Nucleic Acids Res. 31:124–127. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Thummel, K. E., Shen, D. D., Podoll, T. D., Kunze, K. L., Trager, W. F., Hartwell, P. S., Raisys, V. A., Marsh, C. L., McVicar, J. P., Barr, D. M., Perkins, J. D. (1994). Use of midazolam as a human cytochrome P450 3A probe: I. In vitro-in vivo correlations in liver transplant patients.J. Pharmacol. Exp. Ther. 271:549–556. [PUBMED], [INFOTRIEVE], [CSA]
  • Tsuruo, T., Iida, H., Tsukagoshi, S., Sakurai, Y. (1981). Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil.Cancer Res. 41:1967–1972. [PUBMED], [INFOTRIEVE]
  • Tukey, R. H., Strassburg, C. P. (2000). Human UDP-glucuronosyltransferases: metabolism, expression, and disease.Annu. Rev. Pharmacol. Toxicol. 40:581–616. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Ueda, K., Taguchi, Y., Morishima, M. (1997). How does P-gp recognise its substrates?Semin. Cancer Biol. 8:151–159. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Upton, A., Johnson, N., Sandy, J., Sim, E. (2001). Arylamine N-acetyltransferases- of mice, men and microorganisms.Trends Pharmacol. Sci. 22:140–146. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Van Der Hel, O. L., Peeters, P. H., Hein, D. W., Doll, M. A., Grobbee, D. E., Kromhout, D., Bas Bueno De Mesquita, H. (2003). NAT2 slow acetylation and GSTM1 null genotypes may increase postmenopausal breast cancer risk in long-term smoking women.Pharmacogenetics 13:399–407., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • van Schaik, R. H., de Wildt, S. N., van Iperen, N. M., Uitterlinden, A. G., van den Anker, J. N., Lindemans, J. (2000). CYP3A4-V polymorphism detection by PCR-restriction fragment length polymorphism analysis and its allelic frequency among 199 Dutch Caucasians.Clin. Chem. 46:1834–1836. [PUBMED], [INFOTRIEVE], [CSA]
  • van Schaik, R. H., de Wildt, S. N., Brosens, R., van Fessem, M., van den Anker, J. N., Lindemans, J. (2001). The CYP3A4*3 allele: is it really rare?Clin. Chem. 47:1104–1106. [PUBMED], [INFOTRIEVE], [CSA]
  • van Schaik, R. H., van der Heiden, I. P., van den Anker, J. N., Lindemans, J. (2002). CYP3A5 variant allele frequencies in Dutch Caucasians.Clin. Chem. 48:1668–1671. [PUBMED], [INFOTRIEVE], [CSA]
  • Venter, J. C., Adams, M. D., Myers, E. W., Li, P. W., Mural, R. J., Sutton, G. G., Smith, H. O., Yandell, M., Evans, C. A., Holt, R. A., Gocayne, J. D., Amanatides, P., Ballew, R. M., Huson, D. H., Wortman, J. R., Zhang, Q., Kodira, C. D., Zheng, X. H., Chen, L., Skupski, M., Subramanian, G., Thomas, P. D., Zhang, J., Gabor Miklos, G. L., Nelson, C., Broder, S., Clark, A. G., Nadeau, J., McKusick, V. A., Zinder, N., Levine, A. J., Roberts, R. J., Simon, M., Slayman, C., Hunkapiller, M., Bolanos, R., Delcher, A., Dew, I., Fasulo, D., Flanigan, M., Florea, L., Halpern, A., Hannenhalli, S., Kravitz, S., Levy, S., Mobarry, C., Reinert, K., Remington, K., Abu-Threideh, J., Beasley, E., Biddick, K., Bonazzi, V., Brandon, R., Cargill, M., Chandramouliswaran, I., Charlab, R., Chaturvedi, K., Deng, Z., Di Francesco, V., Dunn, P., Eilbeck, K., Evangelista, C., Gabrielian, A. E., Gan, W., Ge, W., Gong, F., Gu, Z., Guan, P., Heiman, T. J., Higgins, M. E., Ji, R. R., Ke, Z., Ketchum, K. A., Lai, Z., Lei, Y., Li, Z., Li, J., Liang, Y., Lin, X., Lu, F., Merkulov, G. V., Milshina, N., Moore, H. M., Naik, A. K., Narayan, V. A., Neelam, B., Nusskern, D., Rusch, D. B., Salzberg, S., Shao, W., Shue, B., Sun, J., Wang, Z., Wang, A., Wang, X., Wang, J., Wei, M., Wides, R., Xiao, C., Yan, C., Yao, A., Ye, J., Zhan, M., Zhang, W., Zhang, H., Zhao, Q., Zheng, L., Zhong, F., Zhong, W., Zhu, S., Zhao, S., Gilbert, D., Baumhueter, S., Spier, G., Carter, C., Cravchik, A., Woodage, T., Ali, F., An, H., Awe, A., Baldwin, D., Baden, H., Barnstead, M., Barrow, I., Beeson, K., Busam, D., Carver, A., Center, A., Cheng, M. H., Romblad, D., Ruhfel, B., Scott, R., Sitter, C., Smallwood, M., Stewart, E., Strong, R., Suh, E., Thomas, R., Tint, N. N., Tse, S., Vech, C., Wang, G., Wetter, J., Williams, S., Williams, M., Windsor, S., Winn-Deen, E., Wolfe, K., Zaveri, J., Zaveri, K., Abril, J. F., Guigo, R., Campbell, M. J., Sjolander, K. V., Karlak, B., Kejariwal, A., Mi, H., Lazareva, B., Hatton, T., Narechania, A., Diemer, K., Muruganujan, A., Guo, N., Sato, S., Bafna, V., Istrail, S., Lippert, R., Schwartz, R., Walenz, B., Yooseph, S., Allen, D., Basu, A., Baxendale, J., Blick, L., Caminha, M., Carnes-Stine, J., Caulk, P., Chiang, Y. H., Coyne, M., Dahlke, C., Mays, A., Dombroski, M., Donnelly, M., Ely, D., Esparham, S., Fosler, C., Gire, H., Glanowski, S., Glasser, K., Glodek, A., Gorokhov, M., Graham, K., Gropman, B., Harris, M., Heil, J., Henderson, S., Hoover, J., Jennings, D., Jordan, C., Jordan, J., Kasha, J., Kagan, L., Kraft, C., Levitsky, A., Lewis, M., Liu, X., Lopez, J., Ma, D., Majoros, W., McDaniel, J., Murphy, S., Newman, M., Nguyen, T., Nguyen, N., Nodell, M., Pan, S., Peck, J., Peterson, M., Rowe, W., Sanders, R., Scott, J., Simpson, M., Smith, T., Sprague, A., Stockwell, T., Turner, R., Venter, E., Wang, M., Wen, M., Wu, D., Wu, M., Xia, A., Zandieh, A., Zhu, X. (2001). The sequence of the human genome.Science 291:1304–1351. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Vineis, P., Veglia, F., Benhamou, S., Butkiewicz, D., Cascorbi, I., Clapper, M. L., Dolzan, V., Haugen, A., Hirvonen, A., Ingelman-Sundberg, M., Kihara, M., Kiyohara, C., Kremers, P., Le Marchand, L., Ohshima, S., Pastorelli, R., Rannug, A., Romkes, M., Schoket, B., Shields, P., Strange, R. C., Stucker, I., Sugimura, H., Garte, S., Gaspari, L., Taioli, E. (2003). CYP1A1 T3801 C polymorphism and lung cancer: a pooled analysis of 2451 cases and 3358 controls.Int. J. Cancer 104:650–657. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • von Ahsen, N., Ritcher, M., Grupp, C., Ringe, B., Oellerich, M., Armstrong, V. W. (2001). No influence of MDR-1 C3435T polymorphism or a CYP3A4 promoter polymorphism(CYP3A4-V allele) on dose-adjusted cyclosporine A trough concentrations or rejection incidence in stable renal transplant recipients.Clin. Chem. 47:1048–1052. [PUBMED], [INFOTRIEVE], [CSA]
  • Walker, A. H., Jaffe, J. M., Gunasegaram, S., Cummings, S. A., Huang, C. S., Chern, H. D., Olopade, O. I., Weber, B. L., Rebbeck, T. R. (1998). Characterization of an allelic variant in the nifedipine-specific element of CYP3A4: ethnic distribution and implications for prostate cancer risk. Mutations in brief no. 191. Online.Hum. Mutat. 12:289. [PUBMED], [INFOTRIEVE], [CSA]
  • Wandel, C., Witte, J. S., Hall, J. M., Stein, C. M., Wood, A. J., Wilkinson, G. R. (2000). CYP3A activity in African American and European American men: population differences and functional effect of the CYP3A4*1B 5′-promoter region polymorphism.Clin. Pharmacol. Ther. 68:82–91. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Wang, C. Y., Jones, R. F., Debiec-Rychter, M., Soos, G., Haas, G. P. (2002). Correlation of the genotypes for N-acetyltransferases 1 and 2 with double bladder and prostate cancers in a case-comparison study.Anticancer Res. 22:3529–3535. [PUBMED], [INFOTRIEVE], [CSA]
  • Wargovich, M. J., Woods, C., Hollis, D. M., Zander, M. E. (2001). Herbals, cancer prevention and health.J. Nutr. 131:3034S–3036S. [PUBMED], [INFOTRIEVE]
  • Wasserman, E., Myara, A., Lokiec, F., Goldwasser, F., Trivin, F., Mahjoubi, M., Misset, J. L., Cvitkovic, E. (1997). Severe CPT-11 toxicity in patients with Gilbert's syndrome: two case reports.Ann. Oncol. 8:1049–1051. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Watkins, P. B. (1994). Noninvasive tests of CYP3A enzymes.Pharmacogenetics 4:171–184. [PUBMED], [INFOTRIEVE], [CSA]
  • Waxman, D. J. (1999). P450 gene induction by structurally diverse xenochemicals: central role of nuclear receptors CAR, PXR, and PPAR.Arch. Biochem. Biophys. 369:11–23. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Weber, W. W., Hein, D. W. (1985). N-acetylation pharmacogenetics.Pharmacol. Rev. 37:25–79. [PUBMED], [INFOTRIEVE]
  • Weinshilboum, R. M., Sladek, S. L. (1980). Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity.Am. J. Hum. Genet. 32:651–652. [PUBMED], [INFOTRIEVE]
  • Weinshilboum, R. (2001). Thiopurine pharmacogenetics: clinical and molecular studies of thiopurine methyltransferase.Drug Metab. Dispos. 29:601–605. [PUBMED], [INFOTRIEVE], [CSA]
  • Weinshilboum, R. (2003). Inheritance and drug response.N. Engl. J. Med. 348:529–537. [PUBMED], [INFOTRIEVE], [CSA]
  • Weinshilboum, R. M., Otterness, D. M., Szumlanski, C. L. (1999). Methylation pharmacogenetics: catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase.Annu. Rev. Pharmacol. Toxicol. 39:19–52. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Westlind, A., Lofberg, L., Tindberg, N., Andersson, T. B., Ingelman-Sundberg, M. (1999). Interindividual differences in hepatic expression of CYP3A4: relationship to genetic polymorphism in the 5′-upstream regulatory region.Biochem. Biophys. Res. Commun. 259:201–205. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Westlind-Johnsson, A., Malmebo, S., Johansson, A., Otter, C., Andersson, T. B., Johansson, I., Edwards, R. J., Boobis, A. R., Ingelman-Sundberg, M. (2003). Comparative analysis of cyp3a expression in human liver suggests only a minor role for cyp3a5 in drug metabolism.Drug Metab. Dispos. 31:755–761. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Wikman, H., Thiel, S., Jager, B., Schmezer, P., Spiegelhalder, B., Edler, L., Dienemann, H., Kayser, K., Schulz, V., Drings, P., Bartsch, H., Risch, A. (2001). Relevance of N-acetyltransferase 1 and 2 (NAT1, NAT2) genetic polymorphisms in non-small cell lung cancer susceptibility.Pharmacogenetics, 11:157–168. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Williams, J. A., Ring, B. J., Cantrell, V. E., Jones, D. R., Eckstein, J., Ruterbories, K., Hamman, M. A., Hall, S. D., Wrighton, S. A. (2002). Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7.Drug Metab. Dispos. 30:883–891. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Wong, J. M., Okey, A. B., Harper, P. A. (2001). Human aryl hydrocarbon receptor polymorphisms that result in loss of CYP1A1 induction.Biochem. Biophys. Res. Commun. 288:990–996., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Wrighton, S. A., Brian, W. R., Sari, M. A., Iwasaki, M., Guengerich, F. P., Raucy, J. L., Molowa, D. T., Vandenbranden, M. (1990). Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3).Mol. Pharmacol. 38:207–213. [PUBMED], [INFOTRIEVE], [CSA]
  • Wu, M. T., Lee, J. M., Wu, D. C., Ho, C. K., Wang, Y. T., Lee, Y. C., Hsu, H. K., Kao, E. L. (2002). Genetic polymorphisms of cytochrome P4501A1 and oesophageal squamous-cell carcinoma in Taiwan.Br. J. Cancer. 87:529–532. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Xie, W., Evans, R. M. (2001). Orphan nuclear receptors: the exotics of xenobiotics.J. Biol. Chem. 276:37739–37742. [PUBMED], [INFOTRIEVE]
  • Xie, H. G., Kim, R. B., Wood, A. J. J., Stein, C. M. (2001). Molecular basis of ethnic differences in drug disposition and response.Annu. Rev. Pharmacol. Toxicol. 41:815–850. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Yan, L., Zhang, S., Eiff, B., Szumlanski, C. L., Powers, M., O'Brien, J. F., Weinshilboum, R. M. (2000). Thiopurine methyltransferase polymorphic tandem repeat: genotype-phenotype correlation analysis.Clin. Pharmacol. Ther. 68:210–219. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Yang, Y. M., Conaway, C. C., Chiao, J. W., Wang, C. X., Amin, S., Whysner, J., Dai, W., Reinhardt, J., Chung, F. L. (2002). Inhibition of benzo[a]pyrene-induced lung tumorigenesis in A/J mice by dietary N-acetylcysteine conjugates of benzyl and phenethyl isothiocyanates during the postinitiation phase is associated with activation of mitogen-activated protein kinases and p53 activity and induction of apoptosis.Cancer Res. 62:2–7. [PUBMED], [INFOTRIEVE]
  • Yates, C. R., Krynetski, E. Y., Loennechen, T., Fessing, M. Y., Tai, H. L., Pui, C. H., Relling, M. V., Evans, W. E. (1997). Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance.Ann. Intern. Med. 126:608–614. [PUBMED], [INFOTRIEVE], [CSA]
  • Yates, C. R., Zhang, W., Song, P., Li, S., Gaber, A. O., Kotb, M., Honaker, M. R., Alloway, R. R., Meibohm, B. (2003). The effect of CYP3A5 and MDR1 polymorphic expression on cyclosporine oral disposition in renal transplant patients.J. Clin. Pharmacol. 43:555–564. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Ye, Z., Parry, J. M. (2002). Genetic polymorphisms in the cytochrome P450 1A1, glutathione S-transferase M1 and T1, and susceptibility to colon cancer.Teratog. Carcinog. Mutagen. 22:385–392. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Yoshimoto, K., Echizen, H., Chiba, K., Tani, M., Ishizaki, T. (1995). Identification of human CYP isoforms involved in the metabolism of propranolol enantiomers-N-desisopropylation is mediated mainly by CYP1A2.Br. J. Clin. Pharmacol. 39:421–431. [PUBMED], [INFOTRIEVE], [CSA]
  • Yu, M. W., Chiu, Y. H., Yang, S. Y., Santella, R. M., Chern, H. D., Liaw, Y. F., Chen, C. J. (1999). Cytochrome P450 1A1 genetic polymorphisms and risk of hepatocellular carcinoma among chronic hepatitis B carriers.Br. J. Cancer. 80:598–603. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Zeigler-Johnson, C. M., Walker, A. H., Mancke, B., Spangler, E., Jalloh, M., McBride, S., Deitz, A., Malkowicz, S. B., Ofori-Adjei, D., Gueye, S. M., Rebbeck, T. R. (2002). Ethnic differences in the frequency of prostate cancer susceptibility alleles at SRD5A2 and CYP3A4.Hum. Hered. 54:13–21. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Zhang, Z., Fasco, M. J., Huang, Z., Guengerich, F. P., Kaminsky, L. S. (1995). Human cytochromes P4501A1 and P4501A2: R-warfarin metabolism as a probe.Drug Metab. Dispos. 23:1339–1346. [PUBMED], [INFOTRIEVE], [CSA]
  • Zhang, J., Kuehl, P., Green, E. D., Touchman, J. W., Watkins, P. B., Daly, A., Hall, S. D., Maurel, P., Relling, M., Brimer, C., Yasuda, K., Wrighton, S. A., Hancock, M., Kim, R. B., Strom, S., Thummel, K., Russell, C. G., Hudson, J. R. Jr, Schuetz, E. G., Boguski, M. S. (2001). The human pregnane X receptor: genomic structure and identification and functional characterization of natural allelic variants.Pharmacogenetics 11:555–572. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Zhao, B., Lee, E. J., Wong, J. Y., Yeoh, P. N., Gong, N. H. (1995). Frequency of mutant CYP1A1, NAT2 and GSTM1 alleles in normal Indians and Malays.Pharmacogenetics 5:275–280. [PUBMED], [INFOTRIEVE], [CSA]
  • Zhao, B., Seow, A., Lee, E. J., Poh, W. T., Teh, M., Eng, P., Wang, Y. T., Tan, W. C., Yu, M. C., Lee, H. P. (2001). Dietary isothiocyanates, glutathione S-transferase-M1, -T1polymorphisms and lung cancer risk among Chinese women in Singapore.Cancer Epidemiol. Biomark. Prev. 10:1063–1067. [CSA]
  • Zheng, H., Webber, S., Zeevi, A., Schuetz, E., Zhang, J., Bowman, P., Boyle, G., Law, Y., Miller, S., Lamba, J., Burckart, G. J. (2003). Tacrolimus dosing in pediatric heart transplant patients is related to CYP3A5 and MDR1 gene polymorphisms.Am. J. Trans. 3:477–483. [CSA], [CROSSREF]
  • Zhong, S., Howie, A. F., Ketterer, B., Taylor, J., Hayes, J. D., Beckett, G. J., Wathen, C. G., Wolf, C. R., Spurr, N. K. (1991). Glutathione S-transferase mu locus: use of genotyping and phenotyping assays to assess association with lung cancer susceptibility.Carcinogenesis 12:1533–1537. [PUBMED], [INFOTRIEVE], [CSA]
  • Zhong, S., Wolf, C. R., Spurr, N. K. (1993). Chromosomal assignment and linkage analysis of the human glutathione S-transferase mu gene (GSTM1) using intron specific polymerase chain reaction.Hum. Genet. 90:435–439.
  • Zhou, Y., Gottesman, M. M., Pastan, I. (1999). Studies of human MDR1-MDR2 chimeras demonstrate the functional exchangeability of a major transmembrane segment of the multidrug transporter and phosphatidylcholine flippase.Mol. Cell. Biol. 19:1450–1459. [PUBMED], [INFOTRIEVE]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.